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SUMMARY
African animal trypanosomiasis affects about half of the 
habitable land in Africa hampering improvements in livestock 
production and mixed agriculture. Though the annual economic 
losses have been difficult to quantify, the disease is a major 
economic handicap to the continent and denies its ever-growing 
population much needed food and livestock products.
In this study, chapter one provides a review of African 
animal trypanosomiasis with regard to its aetiology, hosts, 
geographical location and economic importance, life cycle and 
transmission, pathogenesis, clinical signs, diagnosis and 
control. Of the various methods which are employed in 
controlling the disease, chemotherapy and chemoprophylaxis remain 
the most widespread. However, the trypanocidal drugs in use 
today have been used for over 30 years and problems such as drug 
resistance appear to be increasingly reported.
The remaining chapters deal with various immunochemical 
studies of isometamidium chloride, the main trypanocidal drug 
used in the treatment and control of the disease. In chapter 
two, details of purifying an anti-isometamidium antibody produced 
in sheep and its use in the quantification of isometamidium 
chloride in sera of treated cattle by enzyme linked immunosorbent 
assay (ELISA) are given. The levels of free and bound 
isometamidium in sera of treated cattle were assessed by 
employing trichloroacetic acid precipitation and ultrafiltration 
methods. It was found that, in cattle treated by an
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intramuscular injection of isometamidium chloride, about 95-99% 
of the circulating drug is bound to serum proteins and very 
little if any of it is free and unbound.
In chapter three, details of a "Chemiluminescent Western- 
blot technique" are given. This technique was used in the 
characterisation of the serum proteins that bind isometamidium. 
These proteins were shown to be about 122, 140 and 155 kD in
cattle and about 300 kD in mice and goat. The major 
isometamidium binding proteins in cattle appear to be serum 
albumin. The significance of such bindings in treated animals 
are discussed.
The possibility of developing and using a new technique, 
"Chemiluminescent dot-blot" for the measurement of isometamidium 
in sera of treated animals is examined in chapter four. With 
improvements this new technique may offer a simple, quick, less 
expensive and sensitive method for the quantification of 
isometamidium chloride in body fluids under field conditions.
Chapter five gives the general conclusions drawn from this 
study and future areas of immunochemical research of 
isometamidium chloride are suggested.
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CHAPTER ONE
INTRODUCTION AND LITERATURE REVIEW
3
TRYPANOSOMIASIS - DEFINITION AND AETIOLOGY
Trypanosomiasis is an a c u t e , subacute or more commonly a 
chronic disease of man and animals caused by various species of 
trypanosomes. It is clinically characterised by intermittent
relapses of fever, anaemia, chronic wasting and death.
In Africa, the most important trypanosome species are those 
transmitted by tsetse flies (Gloss ina spp) particularly, 
T-l v iv a x . T . congolense and T_^  b ruce i in ruminants; Th_ uni forme ,
T . suis and T^ simiae in p 
T . b rucei rhodesiense in man.
Trypanosomes are prot 
Trypan o soma belonging to the 
stream forms are elongated, sp 
long. They all possess a fla 
from a basal body at the foot 
the anterior end of the body, 
its entire length to the pelli 
thereafter, it may continue 
centrally placed oval nucle 
structure, the kinetoplast, 
mitochondrion adjacent to the 
stained specimen (Mulligan, 19
Trypanosomes possess a 
which uniformly covers the en 
coat is predominently compose
i g s ; and T . brucei gamb i ense and
ozoan paras ites of the genus
order Kine toplastida Th e blood
indie shaped organisms of 8 - 3 9 um
gellum ar is ing at the pos te rior end
of a flagell ar pocket , and runs to
The f lage llum is a ttache d along
cle to form an undula ting m e m b r a n e ;
f orwa rd as a free flage11 u m . A
u s ; and a small dense staining
whi ch is a DNA of a single
f lage liar pocket can be se en in a
70).
surface coat of about 15 nm thick 
tire plasma membrane. This cell 
d of a single glycoprotein molecule
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of about 65 kDa, and is only visible at the ultrastructural level 
(Vickerman and Barry, 1982; Pays, 1986; Barbet et al, 1989).
HOSTS
There are large numbers of different strains of each 
trypanosome species which show wide varying virulence for the 
hosts. In domestic animals, susceptibility varies greatly with 
the different species of trypanosomes.
Table 1
Susceptibility of Domestic Animals to Pathogenic Trypanosomes
(from Mulligan, 1970)
Trypanosomes
Host
Cattle Sheep Goat Pig Horse
T . vivax + ++ ++ _ +++ or +
T. congolense +++ ++ ++ + ++
T. brucei + + ++ + +++
T. uniforme -H- ++ ++ - ++
T. suis - - - ++ -
T. simiae - + ++ +++ -
(+++ : Highly Susceptible; ++ : Susceptible;
+ : Low Susceptibility; + : May or may not be Susceptible; 
- : Not Susceptible)
The susceptibility also differs with different breeds within 
some domestic animal species. In cattle, breeds that have shown 
resistance or reduced susceptibility (trypanotolerance) to 
trypanosome infections include, West African Longhorn-Ndama, West 
African Shorthorn (Murray et al, 1981; Murray and Trail, 1984; 
Roelants, 1986; Akol et al, 1986; Ikede and Taiwo, 1986; Roelants 
et al, 1987; Pinder et al, 1988) and East African Orma Boran
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(Dolan et al, 1986; Ismael et al, 1986). Indigenous breeds of 
sheep and goats in East and West Africa have also been shown to 
be more resistant than exotic breeds (Griffin and Allonby, 1979; 
Munyua, 1986; Kanyari et al, 1986; Mutayoba et al, 1988).
In most of the wild animal species, despite high infection 
rates, the pathogenicity of the trypanosomes is generally low. 
For example, infection rates of about 30 - 50% have been observed 
in normal eland, bushbuck, giraffe, reedbuck, kudu and waterbuck; 
whereas in buffalo, roan antelope, hartebeeste, impala, duiker, 
warthog and bushpig the infection rates are 10 - 15% (Mulligan, 
1970) .
However, some trypanosome infections are fatal in wild 
animals, for example, brucei in Thomson's gazelle, dikdik,
wild foxes, jackals, hyrax and blue forest duiker; and T\_ vivax 
in red-fronted gazelle (Henson and Noel, 1979).
Despite T^ brucei brucei being morphologically identical in 
all its phases of life cycle to T.b. rhodesiense and 
T.b. gambiense the causative agents of the more acute East 
African and the more chronic West African human sleeping sickness 
respectively, it does not appear to infect man and is confined to 
wild and domestic ungulates and carnivores (Vickerman and Barry, 
1982; Boothroyd, 1985).
GEOGRAPHICAL LOCATION AND ECONOMIC IMPORTANCE
The incidence of African trypanosomiasis in domestic 
animals, particularly ruminants, is directly related to the 
distribution of tsetse flies which is, in turn, influenced by the
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climatic conditions. Three main ecological groups are found:-
(a) The fusca group (subgenus Austerina): These are the forest
tsetse, which are difficult to find and catch, and are of 
least economic importance;
(b) The palpalis group (subgenus Nemorhina) : These are the
riverine tsetse, which are important vectors of human 
trypanosomiasis. Some are also important vectors of animal
trypanosomiasis;
(c) The morsitans groups (subgenus Glossina): These are the 
savannah tsetse which are very important vectors of animal 
trypanosomiasis. They are found almost throughout the year, 
however they retreat to denser woodland and other refuges 
during the hot, dry season.
In Africa, an area of about 10 million square kilometres 
between latitudes 14°N and 29°S is tsetse infested. This is 37% 
of the continent, and about half of the habitable land affecting 
37 countries (Urquhart and Holmes, 1987; Trail et al, 1985). The 
extent of infestation ranges from one country to another, in 
Tanzania for example, 70% of its land is tsetse infested and 
trypanosomiasis was responsible for about 74,818 cattle deaths 
between 1982 and 1986; this being the second major disease after 
East Coast Fever (Mbwambo et al, 1988).
Hendy et al (1986) reported mortalities due to 
trypanosomiasis in Southern Somalia of 30%, 10% and 8% in cattle, 
sheep and goats respectively. In cattle, it amounted to 12 - 14% 
of the herd per year in areas of moderate to high tsetse fly 
infestation.
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Trail et al (1985) argued that 7 million square kilometres 
of the tsetse infested area could be suitable for livestock and 
mixed agriculture. It could support a further 140 million cattle 
and equivalent numbers of sheep and goats.
The annual loss in Africa due to tsetse and trypanosomiasis 
in meat and milk production, draught power and manure in mixed 
agriculture, and biogas is difficult to quantify. However, if 
all these factors are taken into consideration, it is estimated 
that the development of livestock and agriculture in tsetse 
infested areas could generate a further US dollars, 50 billion 
annually (Trail et al, 1985).
Human sleeping sickness in Africa is solely due to 
T.b. gambiense and T.b. rhodesiense infections. Man is 
refractory to T^ vivax, T^ congolense, T. uniforme, T_^  simiae and 
T. suis (tsetse transmitted trypanosomes), and there are strong 
indications that he is highly resistant to infection by 
T . brucei brucei organisms (Stephen, 1986). However, there has 
been some indications of changes in resistance to human serum 
occurring in some animal isolates of T^ brucei brucei, and this 
poses a high likelihood of a zoonosis (The Merck Veterinary, 
1986).
LIFE CYCLE AND TRANSMISSION
The African pathogenic trypanosomes undergo a cycle of 
development only in an insect host, the tsetse fly, following the 
fly's ingestion of blood from a trypanosome infected animal 
before they are transmitted to a new host by a fly bite. This is 
referred to as "cyclical transmission". In the fly, the
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trypanosomes lose their surface coat after being ingested; they 
then multiply and develop to trypomastigotes, epimastigotes and 
finally the metatrypanosomes (metacyclic forms) which re-acquires 
a surface coat and becomes infective for another mammalian host 
(Mulligan, 1970).
The development sites for the three stages of trypanosomes 
vary in each species and may be used as a criterion for 
identification. vivax has an invertebrate life cycle of 7 -
13 days multiplying and developing in the fly mouth parts only. 
T . congolense develop in the midgut as long trypomastigotes, then 
migrate to the proboscis where they assume the epimastigote form; 
all forms lacking a free flagellum. They multiply for some time 
still being attached to the proboscis wall before they pass into 
the hypopharynx where they develop into trypomastigotes. This 
cycle lasts for 15 to 20 days (Levine, 1985).
The T^ brucei life cycle in the tsetse fly takes 15 to 35 
days. Following ingestion, localisation occurs in the posterior 
part of the mid-gut, where they develop and multiply in the 
trypomastigote form for about ten days. These are at first 
relatively broad; later, slender forms appear which migrate to 
the proventriculus between days 12 and 20. Further migration 
occurs to the oesophagus, pharynx, hypopharynx and finally into 
the salivary glands. It is in the salivary glands that the 
trypomastigotes develop into epimastigotes, multiply further, 
then transform into small and stumpy metatrypanosomes having a 
short free flagellum (Stephen, 1986; Levine, 1985).
Under natural conditions, the infection rates in tsetse
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flies is low, rarely exceeding 20%. In African animal 
trypanosomiasis, tsetse flies are the primary transmitters, with 
wild animals as the main reservoirs of infection. However, 
mechanical transmission has also been reported (Mulligan, 1970; 
Henson and Noel, 1979; Stephen, 1986; Levine, 1985; Urquhart and 
Holmes, 1987). Trypanosomes on mouthparts of tsetse flies and 
other biting flies such as Tabanus, Stomoxys, Chrysops, 
Haematopata and Pangonia can be passed from host to host during 
interrupted feeding. T\_ vivax is commonly transmitted
mechanically on the fringe of tsetse areas. Prenatal 
transmission at parturition, and on surgical instruments and 
needles, rarely do occur.
Ikede and Lossos (1972) reported intrauterine transmission 
in pregnant sheep and Ogwu et al (1986) in cattle infected with 
T . vivax.
PATHOGENESIS, CLINICAL SIGNS AND PATHOLOGICAL FEATURES 
PATHOGENESIS
Skin Reaction
Within 5 - 8  days after an animal has been bitten by a 
tsetse fly, the multiplying metacyclic trypanosomes cause the 
development at the site of the bite of an inflamed, oedematous, 
raised cutaneous swelling of several centimetres in diameter, 
which persists for two to three weeks. This skin lesion is 
referred to as "chancre". The chancre develops only following a 
bite by trypanosome infected fly, and trypanosomes are found
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extravasculary within the chancre (Morrison et al, 1985).
Generally, T\_ congolense and T\_ brucei produce local skin 
reactions which can measure up to 10 cm in diameter, whereas 
T . vivax produce a much smaller reaction of 2 - 3 cm diameter at 
maximum. With some vivax strains, no detectable reaction 
develops, for example, isolated stocks of vivax from Kilifi, 
Kenya, reported by Paling et al (1987).
The cells found within the chancre are polymorphonuclear 
leukocytes and large numbers of lymphocytes and plasma cells. 
The appearance of the chancre is followed within a few days by 
detectable parasitaemia, fever and marked enlargement of the 
draining lymph nodes.
Lymphoid System Changes
The lymph nodes draining the chancre are first enlarged 
followed by a generalised lymphadenopathy and splenomegaly which 
is associated with marked proliferation of lymphoid cells. 
Numerous large active germinal centres develop, and a marked 
increase of plasma cells occur in the medullary cord of the lymph 
nodes and splenic red pulp. There is also an increase in the 
splenic red pulp of active macrophages, some of which are engaged 
in erythrophagocytosis. Hepatic Kupffer cells are also increased 
in number and activity, and a pronounced hypergamma-globulinaemia 
occurs concurrently with these changes. Despite the pronounced 
activation of the lymphoid system, immunosuppression has been 
demonstrated by significant reduction in humoral responses to a 
variety of infectious agents (antigens) in trypanosome infected 
animals (Scott et al, 1977; Whitelaw et al, 1979; Rurangirwa
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et al, 1983).
In chronic infections, the lymphoid organs may be decreased 
in size with depletion of lymphoid cells.
Circulatory Changes
(a) Anaemia
Anaemia is a reliable indicator of the progress or severity 
of trypanosomiasis as demonstrated by packed cell volume (PCV) 
values, and it can be divided into two phases.
The onset and severity of anaemia in the first phase is 
directly related to the appearance of the trypanosomes in the
circulation, and the level and duration of parasitaemia. This
phase may last four to six weeks after infection (Holmes and 
Jennings, 1976; Dargie et al, 1979; Morrison et al, 1985).
Studies by Jennings et al (1974) and Mamo and Holmes (1975), 
demonstrated that the principal factor causing anaemia is 
accelerated red blood cell loss from the circulation. The loss 
is a result of erythrophagocytosis in the spleen, lungs, haemal 
nodes, bone marrow, and is particularly marked in the liver. 
There is evidence that, immunological factors play a significant 
role in erythrophagocytosis in that, antibodies specific for 
trypanosomes become complexed with antigen on the erythrocytes 
(erythrocyte sensitisation) resulting in red cell sequestration 
and destruction in the reticulo-endothelial system (RES). The 
erythrocytes are destroyed through phagocytosis via fragment
crystallisalde (FC) and complement receptors on the macrophage 
(Murray and Dexter, 1988).
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Fever increases erythrocyte fragility, and the damaged red 
cell membrane may bind antigen-antibody complexes or complement 
more readily and therefore, facilitating erythrophagocytosis. 
Pathogenic trypanosomes produce a haemolytic factor of low 
molecular weight (about 10 kD) and protein in nature causing 
direct lysis of erythrocytes (Jenkins and Facer, 1985).
The expanded and active mononuclear system, may also be a 
contributory cause to increased red cell destruction (Urquhart 
and Holmes, 1987). In a trypanosome infected animal, the non­
specific activation of the RES and pooling of red cells within 
the enlarged spleen may result in increased removal of normal 
erythrocytes and injurious effects on red cells with increased 
osmotic fragility.
Though occasionally, petechiations and ecchymoses are found 
scattered in animal organs and tissues, widespread haemorrhage is 
not a feature in animal trypanosomiasis, except with some 
isolates of T^ vivax. Intravascular haemolysis has also not been 
shown to contribute significantly to the anaemia of this stage. 
Usually the anaemia is normocytic normochronic, however, 
macrocytic responses have also been observed (Murray and Dexter, 
1988).
Treatment of trypanosome infected animals during the first 
phase with trypanocidal drugs, usually results in rapid recovery 
of PCV and other haematological values (Holmes and Jennings, 
1976).
The second phase is characterised by a low grade, more 
chronic anaemia found in animals with chronic trypanosomiasis,
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and usually occurs between four to six months after infection in 
cattle. There is low transient parasitaemia or complete absence
of detectable parasites in circulation, the PCV values stabilises 
at 20 - 25%, and the animal responds poorly or fails to respond 
haematologically to trypanocidal drug treatment (Murray and 
Dexter, 1988).
The anaemia in this chronic phase is thought to be due to 
dyshaemopoesis. There is lack of incorporation of iron into the 
developing red cell precursors, a decrease in erythrocyte 
production by the bone marrow, and an intrinsic modest reduction 
in red cell survival. The principle cause lies in some 
impairment of bone marrow function; the femoral marrow is often 
gelatinous and inactive, and there is a large excess of stored 
iron not used for haemoglobin synthesis (Jenkins and Facer, 
1985). Murray and Dexter (1988) speculated that red cell
autoantibodies or trypanosome mediated antigen-antibody reactions 
might contribute to stem cell destruction.
(b) Abnormal Haemostasis
Jenkins and Facer (1985) indicated that the major 
haemostatic factors which appear to be involved in the pathology 
of trypanosomiasis are vascular injury, coagulopathy with 
increased fibrinolysis, and thrombocytopenia.
It has been suggested that release of pharmacologically
active substances leads to collection of platelets and
circulating leucocytes which causes occlusions and finally the 
blood vessels disintegrate. The vascular damage is manifested by 
petechiae and leakage of fluid and protein into extravascular
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spaces, and is particularly noticeable in experimental infections 
with T_;_ brucei.
Disseminated (widespread) intravascular coagulation (DIC) 
also known as consumption coagulopathy, or defibrination 
syndrome, is a dynamic pathological process triggered by 
activation of the clotting cascade, and can be manifested as a 
wide clinical spectrum. DIC with associated fibrinolysis is 
responsible for the thrombosis, haemorrhage, tissue necrosis and 
microangiopathic haemolytic anaemia found in acute 
trypanosomiasis. Murray and Dexter (1988), suggested that 
microangiopathy most likely play a significant role in acute 
infections with T\_ vivax which are characterised by high 
parasitaemia. Also the microangiopathic changes that occur are 
possibly initiated by thrombocytopaenia and could lead to red 
cell damage and finally to phagocytosis.
Increased serum fibrin/fibrinogen degradation products 
(FDPs) in trypanosomiasis indicates increased fibrinolysis and 
DIC (Jenkins and Facer, 1985). "Early" FDP fragments (X and Y) 
are powerful inhibitors of blood coagulation having antithrombin 
effects and promoting ADP-induced platelet aggregation. The 
"late" FDP fragments, protentiate biogenic amines and peptides, 
increase vascular permeability and have immunosuppressive 
activity.
In trypanosomiasis, thrombocytopaenia and in vivo platelet 
clumping are characteristic features (Jenkins and Facer, 1985). 
Thrombocytopaenia may result from a failure of platelet 
production, increased platelet destruction, or the dilution
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effect of increased plasma volume. A platelet defect in number 
or function results in abnormal haemostasis.
Tissue Lesions
The nature of the cellular infiltrate and possibly the 
mechanism involved in cell injury appear to depend on the 
difference in tissue invasiveness between species of 
trypanosomes.
During the course of the disease, the host responds to a 
series of trypanosome antigenic variants in vivo, by mounting 
antibody responses to clear the variants. Immune complexes of 
trypanosome antigens and parasite-specific IgM or IgG plus 
Complement (C) are formed and deposited in the vasculature and 
extravascular spaces of tissues. These complexes range from 
those with an antigen excess (temporarily) to those with an 
antibody excess in composition, causing inflammatory changes as 
those occurring in Arthus lesions, and in acute and chronic 
immune complex disease (Mansfield, 1981).
The common tissue lesions associated with animal 
trypanosomiasis are found in the heart, skeletal muscle, liver 
and kidneys. The lesions are characterised by muscle fibre 
degeneration, mononuclear cell infiltration and oedema. In the 
heart there is also fibrinous necrosis of the coronary vessels 
and the conducting purkinje fibre system is often widely 
separated from the myocardium by cellular infiltrates and oedema. 
Invasion of tissues with lymphocytes, plasma cells, macrophages 
and a few polymorphonuclear leucocytes may be due to attraction 
by chemotactic factors resulting from complement activation by
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antigen-antibody complexes at the site. In the skeletal muscles, 
the tissue changes may be partly responsible for the emaciation 
which is a characteristic feature of trypanosomiasis, and muscle 
pain in dogs. In T_;_ brucei infections, tissue destruction is 
very marked, and the brain is also involved (Mansfield, 1981; 
Vickerman and Barry, 1982; Urquhart and Holmes, 1987).
Seed and Hall (1985) concluded that major physiological 
changes also occur in African animal trypanosomiasis which are 
important in the pathogenesis of the disease. Formation of toxic 
catabolites and the depletion of essential nutrients for example, 
would alter host metabolism and lead to changes in the major 
metabolic pathways, such as decreased protein synthesis, 
gluconeogenesis and energy production.
CLINICAL SIGNS
The incubation period in African animal trypanosomiasis is 
usually one to four weeks with the severity of the clinical 
disease varying with the species of the animal infected and the 
trypanosome species involved. Generally, the primary clinical 
signs observed are intermittent fever, anaemia and weight loss or 
wasting (Mulligan, 1970); The Merck Veterinary Manual, 1986). 
The disease syndrome may either be acute or chronic with a poorly 
defined line of demarcation.
In cattle, intermittent pyrexia is observed during the early 
stages of infection even before parasitaemia is readily 
detectable. The superficial lymph nodes are palpably enlarged 
and the animal has a bright demeanour with occasional signs of
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loss of appetite though it may continue to eat during the course 
of the disease.
Anaemia is evidenced by the pallor of mucous membranes and 
PCV which falls to 20% or lower (decreased by about 40 - 50%) 
over the first four to six weeks. There is a gradual loss of 
body condition with the severity of anaemia until the animal dies 
(Morrison et al, 1981). The animals show tachycardia during the 
course of disease with bradycardia, pulsating jugulars, weak 
pulse and sometimes subcutaneous oedema terminally.
Affected animals usually trail at the rear of the herd 
during grazing, they are lethargic with a dull coat and show a 
"hunched-up" appearance. Terminally, the animal becomes 
extremely weak and often unable to rise, although there is no 
paraplegia and reflexes are unimpaired (Mulligan, 1970).
Survivors may, after a variable length of time, show gradual 
disappearance of parasitaemia and rising of PCV. However, these 
animals remain unproductive for long periods of time and stunted 
growth occurs in young animals. In adults, there is decreased
fertility and sometimes, pregnant cows abort or give birth to
small weak calves (Morrison et al, 1981; Stephen, 1986).
In chronic disease, the animals have a voracious appetite 
which continues until death, and grass is often found in the 
mouths of dead cattle. A diseased animal is usually thin and
emaciated, the skin is drawn tightly over the ribs and pelvis and
lacks the normal healthy looseness. The hair is rough with 
upstanding appearance, and enlarged subcutaneous supernumerary 
haemolymph glands are easily palpable, particularly over the ribs
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and along the flanks (Mulligan, 1970).
Infection with certain isolates of T_;_ vivax produces an acute 
haemorrhagic syndrome characterised by fever, sustained high 
levels of parasitaemia, blood-stained diarrhoea and death occurs 
within two to four weeks post-infection (Morrison et al, 1981).
Generally, T.b. brucei infection is severe in horses, 
camels, goats, sheep and dogs. In dogs, there is an addition to 
the common clinical signs, conjunctivitis, keratitis and 
blindness (Levine, 1985; Stephen, 1986). Masake et: al (1984) 
reported absence of clinical and histological evidence of 
cerebral trypanosomiasis in cattle infected with T.b. brucei 
alone. They further concluded that Berenil (Hoechst) treatment 
predisposes cattle infected with T.b. brucei to CNS involvement; 
and suggested an interdependence of T.b. brucei and T^ congolense 
mixed infections in the pathogenesis of cerebral trypanosomiasis.
PATHOLOGICAL FEATURES
The gross and histopathological features of animals dying 
from trypanosomiasis have been extensively discussed by Mulligan 
(1970) and Stephen (1986).
Macroscopic Appearance
The common gross lesions observed in ruminants dying from 
trypanosomiasis depend on the stage of the disease, however the 
pathological features are not pathognomonic.
There is gelatinous atrophy of body fat particularly around 
the heart and kidneys, and wasting of skeletal muscle. In 
chronic cases the blood is pale, watery and clots poorly.
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Parenchymatous organs are pale, and often excess serous 
fluid which may be blood tinged is found in the body cavities, 
notably the pericardium and sometimes there is gross oedema of 
the subcutis and viscera.
In early stages of the disease, the spleen is markedly 
enlarged with blunt edges, and the cut surface is drier
showing prominent Malphigian corpuscles. In chronic cases, it is 
small and atrophic and red marrow in long bones (except in ribs 
and vertebrae) disappears and becomes gelatinous.
Usually, there is a generalised lymphadenopathy, the lymph 
nodes are also oedematous and haemorrhagic. Sometimes, the 
medullary cells contain dark pigment giving a lymph node a 
blackish appearance. Haemal lymph nodes are markedly enlarged. 
The lymph nodes are commonly smaller than normal and fibrotic in 
chronic cases.
The lungs are oedematous and marbling is observed due to 
dilation of the lymphatic vessels. They do not collapse as 
normal organs and have a firmer consistency. The liver is often 
swollen, firm, congested and dark, while the kidneys are 
nephretic.
The heart is usually pale, hypertrophied, and in advanced 
cases, the ventricles are dilated giving the heart a globular 
appearance. Sometimes, irregular streaks of haemorrhages are 
seen on the epicardium and they may extend to the flabby and 
oedematous myocardium.
Animals dying of hyperacute T_^  vivax infection are normally 
in a good body condition with widespread petechial and ecchymotic
20
haemorrhages on mucosal and serosal surfaces, and sometimes frank 
haemorrhages are found into the gastrointestinal tract.
Microscopic Appearance
Myositis is observed in chronic cases, and especially in 
T.b. brucei infections, wherever trypanosomes are found in the 
connective tissue, an extensive cellulitis occurs in the dermis 
and subcutaneous layers, and there is necrotising vasculitis, 
lymphatic thrombosis, fibrinous exudation and necrosis of
mononuclear and polymorphonuclear inflammatory cells.
Proliferation of lymphocyte follicles is evident in the
cortex of lymph nodes extending to the paracortical zone along
the connective tissue trabeculae. There is an increased number 
of lymphoblasts, immature plasma cells and macrophages in the 
enlarged germinal centres, expanded cortex, paracortex, medullary 
cords and distended sinuses. The medullary reticulum is
hypertrophied and the cells often contain dark-brown pigmented 
granules. In T_^  vivax infections it is common to observe blood 
vessels thrombosed with a mixture of fibrin, red blood cells, 
lymphoid cells and trypanosomes. Phagocytosis and extensive 
deposits of haemosiderin may be found.
In the spleen, there is hypertrophy of lymphoid cells and of 
the mononuclear phagocyte system (MPS or RES). Germinal centres 
are grossly expanded and contain actively proliferating large 
lymphocytes, macrophages and lymphoblasts. Plasma cells and 
macrophages are found in great numbers throughout the splenic 
tissue, even in arteolar sheath regions and red pulp. In 
peracute and chronic infections, regressive changes evidenced by
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focal necroses and fibrosis may be observed.
Obvious heart lesions may be absent in small ruminants, but 
they are severe in cattle. Haemorrhages are common under epi- 
and endo-cardium. With advancement of the disease, the cardiac 
muscles undergo a series of changes from myocarditis to the 
appearance of thin and atrophic muscle fibres. The degenerating 
myocardial fibres are widely separated by interstitial and 
perivascular oedema infiltrated with lymphocytes, macrophages and 
plasma cells. Trypanosomes are commonly contained within the 
dilated capillaries and they may also be observed extravascularly 
There is usually fibrinous necrosis of coronary vessels. 
Fragmentation and lysis of Purkinje cells may sometimes be seen. 
Heart changes are less marked in infections with T^ congolense.
Kidneys show mild nephrosis and chronic glomeruritis with 
mononuclear cell infiltrations which may extend throughout the 
kidneys. Atrophy of the proximal tubules may occur, and 
haemosiderin is present in the tubular epithelium. With 
T . brucei infections, the changes may be more severe.
In the bone marrow, there are infiltrations with islets of 
lymphoblastic tissue, and the haemopoietic tissue is abundant 
containing excess of normoblasts in acute stages. The marrow in 
long bones is practically destroyed in chronic cases. 
Haemosiderosis may be observed.
There is fatty infiltration of the hepatocytes and varying 
degrees of central lobular necrosis is observed in the liver 
parenchyma. Central veins and sinusoids are dilated and the 
Kupffer cells are excessively enlarged containing haemosiderin
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and erythrophagocytosis may be evident. The portal triads are 
infiltrated with lymphocytes, macrophages, plasma cells and 
sometimes morula cells.
Some lung alveoli can be grossly dilated and sometimes 
ruptured. Some may contain fluid, the alveolar cells enlarged 
and swollen, and the alveolar septa is infiltrated with 
lymphocytes, macrophages, plasma cells, collagen fibres and is 
greatly distended with oedema.
Brain lesions have been reported to be found mainly in 
T . brucei infections, however, Masake et al (1984) demonstrated 
that a higher incidence of cerebral trypanosomiasis occurs in 
mixed infections with congolense and brucei than with 
either T^ _ brucei or congolense alone in cattle. In dogs and 
cattle (Morrison et al, 1981) the lesions are characterised by 
cellular infiltrates containing many lymphoblasts and plasma 
cells. These infiltrates are in the meninges and perivasculary 
throughout the brain and spinal cord in cattle; and in the 
choroid plexus and meninges in dogs. Trypanosomes are present in 
cerebral spinal fluid and there is diffuse meningoencephalitis 
(Morrison et al, 1985). In T^ _ vivax infections only perivascular 
cuffing by lymphocytes may be observed.
There is degeneration of seminiferous tubules which are 
devoid of spermatozoa and spermatids. There is also an increase 
in connective tissue surrounding epididymal tubules which are 
also devoid of spermatozoa and spermatids.
Histological lesions reported in the endocrine glands have 
not been constantly observed (Stephen, 1986). They include
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extreme distension of thyroid glands' acini with colloid, and 
where the acini has disintegrated there is mononuclear cell 
infiltrations or fibrosis terminally. In the adrenal glands, 
mononuclear cell infiltrations are observed below the capsule, 
however in some cases they may extend between the bundles of zona 
fascicularis. The whole cortex tends to be necrotic and 
sometimes necrosis and fibrosis extend into the medulla.
IMMUNOLOGY OF AFRICAN ANIMAL TRYPANOSOMIASIS
Trypanosome Antigens
There are two functional groups of antigens in African 
animal trypanosomes; common (stable) antigens and variable 
antigens (Mansfield, 1981; Vickerman and Barry, 1982; Urquhart 
and Holmes, 1987).
The common antigens are components (e.g. structural 
proteins, enzymes) of membranes and organelles found in all 
trypanosomes at all stages of infection, in all stocks of the 
same species, and some in other species. About 30 different 
common antigens may be detected serologically in trypanosome 
extracts. Almost all of these antigens are covered by a surface 
coat and therefore unexposed in the circulating living 
trypanosomes. They are released only when the trypanosomes are 
destroyed. In this respect, the common antigens lack the 
opportunity to contact the relevant immunocytes, and it is 
expected therefore that they elicit only a weak immune response. 
However, Shapiro and Murray (1982) showed that animals that are 
able to recognise certain common antigens control trypanosomiasis
infections more effectively than animals which are unable to 
recognise them. The induction of immunity by these antigens is 
not yet very clear.
The variable antigen is a 12 - 15 run thick surface coat 
covering the plasma membrane of a trypanosome as seen in an 
electron micrograph, representing 10% of all trypanosomes' 
cellular protein. The variable antigens change from one 
population of trypanosomes to another and are responsible for the 
differences between serological variants or variable antigen 
types (VATs) of the trypanosomes. The surface coat of a 
trypanosome is composed of a matrix of a single glycoprotein with 
molecular weight of about 65 kD and composed of 600 amino acids 
and up to 20 carbohydrate residues; the variable surface 
glycoprotein (VSG). The VSG is the variant specific surface 
antigen (VSSA) evoking an antibody response in each parasitaemic 
wave (Mansfield, 1981; Vickerman and Barry, 1982; Urquhart and 
Holmes, 1987). This coat is lost together with the variable 
antigen when a trypanosome undergoes a cyclical development in 
the tsetse fly and is reacquired during the differentiation of 
the metayclic form.
The trypanosomes in mammalian circulation evade the specific 
immune response to the VATs by undergoing antigenic variation, 
that is, switching from expression of one VAT to another. The 
switching is intrinsic occurring spontaneously in a manner that 
does not require the presence of antibody as a stimulus (Stephen, 
1986).
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The number of VATs a single trypanosome can produce is known 
as the VAT repertoire; cloned trypanosomes are capable of 
expressing several hundred VATs, however the exact number is 
still unknown (Vickerman and Barry, 1982; Stephen, 1986). 
Thirty-nine VATs have so far been defined by Gardiner et al
(1986) in T\_ vivax cloned stock; and 101 in T^ equiperdum in 
rabbit ( Capbern et al, 1977). In a natural, tsetse-fly
transmitted infection, each parasitaemic wave consists of many 
subpopulations each expressing a different VAT.
Host Response to Trypanosome Antigens
The mammalian host produces immunoglobulins and develops a 
cellular response to trypanosome infection which is specific for 
the antigenic composition of the infecting organism. However, 
antibodies produced against the common antigens show extensive 
cross-reactions with trypanosome clones of the same species and 
other trypanosome species. There is considerable evidence that 
immunity to trypanosome challenge is mediated by antibody 
responses against the variable surface glycoprotein (VSG). 
Antibodies produced against each VSSA will react only with the 
variable surface antigens of a population of parasites in 
circulation at the particular time during infection, thus the 
measure of protection provided to the animal is against 
antecedent antigenic types. However, due to the ability of the 
African trypanosomes to change their VSSA, the infection 
persists. As the immune response to the antigenically 
predominant population destroys those trypanosomes, the variant 
parasites expressing different VSSA are spared and subsequently
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reproduce to become the next antigenically predominant population 
of the circulation and tissues. Therefore, parasitaemia is 
controlled only superficially, the cycle of antigenic variation 
and immunoselection continuing until the demise of the host 
(Mansfield, 1981; Vickerman and Barry, 1982; Stephen, 1986; 
Morrison et al, 1985; Pays, 1986; Seed and Sechelski, 1988) or 
self cure occurring.
It has been found that, in all infections with any of the 
pathogenic trypanosomes, there is a marked increase in IgM levels 
within two weeks of infection with a little change in IgG 
(Luckins, 1972; Kobayashi and Tizard, 1976; Mackenzie et al, 
1979; Nielsen et al, 1978; Musoke et al, 1981). Musoke et al
(1981) further showed that, during the first three weeks of 
infection, the produced IgM and IgG are specific for the variable 
antigen on the surface of the living trypanosomes and thus have a 
protective function. Also, IgM antibodies seem to be more 
efficient in killing trypanosomes than IgG.
In trypanosomiasis, the host response is unique in that 
following the initial IgM response, IgM continues to rise and 
remains at high levels. It appears also that, the switching 
mechanism from IgM to IgG is uniquely selective for IgG^ heavy 
chains. The dysfunction can be due to hypocomplementamia which 
is a consistent feature in trypanosome infections (Koboyashi and 
Tizard, 1976; Nielsen et al, 1978; Tabel et al, 1980; Musoke 
et al, 1981; Vickerman and Barry, 1982).
It should be noted that antibodies which neutralise 
metacyclic trypanosomes appear in the serum just after the peak
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of the local skin reaction and at the time of initial detection 
of parasitaemia. Thereafter, antibodies are produced to the VATs 
of each successive wave of parasitaemia, and with the progression 
of infection, antibodies against the common antigens are also 
produced (Morrison et al, 1985) . Antibody effects removal of 
circulating trypanosomes in vivo by trypanolysis and opsonisation 
which are followed by Kupffer cell uptake. Extravascularly, 
various macrophages and lysis are expected to effect trypanosomal 
removal.
T-lymphocytes do not appear to play a role in immunity to 
the African trypanosomes and cell mediated immunity reactions do
not appear early in infection, if at all, are not directed
against the all-important surface variable antigen, and are not
involved in protection (Vickerman and Barry, 1982).
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DIAGNOSIS
Diagnosis is a prerequisite in the treatment and control of 
animal diseases either as individual cases, a herd or over a wide 
geographical area.
Epizootiological features are important in making a 
presumptive diagnosis, however, amongst the animal 
trypanosomiases they may vary considerably in different climatic 
areas and regions.
The diagnosis based on clinical and pathological features in 
animal trypanosomiasis poses a considerable problem particularly 
in the presence of other infections that cause anaemia and weight 
loss, such as babesiosis, anaplasmosis and theileriosis despite 
the fact that they can be eliminated by examining stained blood 
and lymph gland smears.
Diagnostic tests are therefore of paramount importance in 
the confirmation of animal trypanosomiasis, especially a test 
that detects a current infection, and can identify and 
differentiate the trypanosome species involved. These tests can 
also be employed when conducting surveys in an attempt to 
determine the overall prevalence and experience of infection.
The diagnosis of animal trypanosomiasis is unsatisfactory as 
no single test is simple and cheap, yet be sufficiently specific, 
sensitive and reproducible to warrant its widespread use in the 
field (Paris et al, 1982; Vickerman and Barry, 1982; Kalu and 
Lawani, 1986).
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Parasitological Tests
These tests make use of tissues removed from the animal body 
particularly blood and to a lesser extent lymph node biopsies. 
Giemsa's stained lymph node smears are useful only in examination 
of T_^  vivax.
Blood samples collected from ear vein are considered to be 
more sensitive indicators of parasitaemia than blood collected 
from jugular vein, especially in cases of T^ _ congolense 
infections. The usually low and transient parasitaemias in 
animal trypanosomiasis, renders the difficulty in finding 
trypanosomes in blood samples with the available parasitological 
tests (Murray et al, 1979; Stephen, 1986). It is believed that 
trypanosomes exhibit a phenomenon of diurnal variation, however 
there are conflicting views as to the best time of the day that 
blood samples should be taken. Greig et al (1979) indicated that 
samples taken around midday are more likely to reveal the 
presence of trypanosome infection than samples taken at other 
times of the day, whereas Stephen (1986) advocates early morning 
sampling. Through my personal experience (unpublished), the best 
times for sampling are early morning and late afternoon in the 
tropics.
The parasitological methods utilising blood for diagnosis of 
animal trypanosomiasis include blood film examination, 
trypanosome concentration techniques, and animal inoculation.
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Blood Film Examination
(a) Wet (Unstained Films)
A small drop of blood is placed on a clean, grease free 
microscope slide and then overlaid with a coverslip such that the 
blood spreads over the area of the coverslip to form a continuous 
single red blood cell film layer. Trypanosomes are detected by 
examining such films with the aid of phase contrast or darkground 
microscopy techniques. Trypanosome species can be differentiated 
based on the type of movement they show in the wet smear, 
however, experience is vital.
This method is relatively inefficient and inferior for the 
detection and identification of trypanosomes particularly when 
large numbers are being examined as in herd surveys (Murray 
et al, 1977; Paris et al, 1982; Ogbunude and Magagi, 1982).
(b) Stained Films
Giema's stain, Romanovsky-type stain, Field's stain and 
Leishman's stain are commonly used in the staining of blood 
films. Giemsa's stain gives the best results, however, for rapid 
examination of large numbers of films, Field's stain is preferred 
due to its short staining time. In large scale trypanosomiasis 
surveys, thick and thin stained blood films are cheap and still 
the commonly used methods.
(i) Thick Stained Blood Films
A few drops of blood, about 5 ul are placed and spread over 
a small area of a microscope slide (1 - 2 cm diameter) giving a 
thick film and left to air-dry completely. Using a freshly 
prepared 10% Giemsa's stain in buffered water pH 7.2, the film is
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stained for 30 minutes. To differentiate the stain, the slide is 
then put in buffered water until the film turns pink. The slide 
is examined under a microscope for trypanosomes after it has air- 
dried. However, this method results in distortion and poor 
preservation of the trypanosome's morphological features.
The morphology of the trypanosomes is much better preserved 
by employing MacLennan's modification in staining thick smears; 
the slide with a dried thick blood smear is immersed in 0.5% 
aqueous methylene blue for one second, rinsed gently and briefly 
with tap water before being stained with Giemsa's stain (Stephen, 
1986) .
The use of thick stained blood films is particularly useful 
in detecting infections with low parasitaemia, whereby the 
trypanosomes are too scanty to be observed in a thin or wet film 
(Mulligan, 1970; Paris et al, 1982).
Table 2
The Threshold Sensitivity (Trypanosome/ml Blood) of Blood Films 
for the Detection of T^ congolense, T. vivax and T^ brucei 
(From Paris et al, 1982)
Method T. congolense T . vivax T. brucei
Thin Film 2.5 x 104 5 x 104 2.5 x 104
Wet Film 1.2 x 104 8.3 x 103 8.3 x 103
Thick Film 8.3 x 103 6.25 x 103 5 x 103
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(ii) Thin Stained Blood Films
A thin blood film is prepared by spreading a drop of blood 
on a clean grease free microscope slide to give a continuous 
single red blood cell film. After the film has air-dried, it is 
fixed with water-free methanol by either covering the film with/ 
or dipping the whole slide in methanol for 1 - 2  minutes. The 
film is then stained as for thick smears with Giemsa's stain.
Since the fixation preserves the morphological 
characteristics of the trypanosomes, species identification is 
possible. Overall length (size), shape of the posterior end and 
presence of free flagellum are commonly used in species 
identification. Size and position of kinetoplast and the 
distribution of cytoplasmic granules are less used, however they 
are valuable in confirmation of the identified trypanosome 
species.
Trypanosomes Concentration Techniques
Trypanosomes in a given volume of blood are concentrated so 
as to increase the probability of their detection, particularly 
in cases of low parasitaemia. The techniques usually involve 
some form of centrifugation and separation of the trypanosomes 
from the host cells.
(a) Silicone Centrifugation Technique
The technique which was developed by Ogbunude and Magaj i
(1982) is based on the differences between the host's red blood 
cells and the trypanosomes' densities. The erythrocytes being of 
greater density than the trypanosomes are pelleted by 
centrifugation through a layer of silicone fluid, whereas the
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trypanosomes remain in the plasma supernatant.
In the technique, 25 Hi of blood is dispensed into a 1.5 ml 
tapered microfuge tube containing 500 p. 1 of silicone fluid 
(specific gravity 1.075) and centrifuged at 150 g for five 
minutes. The plasma supernatant fraction on the top of the 
silicone fluid is then examined as in unstained wet blood films.
Ogbunude and Magaji (1982) reported that the technique 
compared favourably with other microsensitive techniques such as 
the miniature anion exchange centrifugation (m-AECT) and 
microhaematocrit buffy-coat microscopy methods.
(b) Anion-Exchange Centrifugation Techniques - m-AECT 
These techniques make use of the difference in charges 
between the host's erythrocytes and trypanosomes.
(i) Large volumes of about 5 - 10 ml of infected blood are 
passed through a 25 - 100 g column of diethylaminoethyl (DEAE) 
cellulose equilibrated to pH 8.0 with phosphate buffered saline. 
The more negatively charged erythrocytes are adsorbed by the 
positively charged cellulose particles, whereas the trypanosomes 
pass through the eluate. The eluate is examined directly as for 
unstained wet blood films.
(ii) Miniature anion/exchange centrifugation technique 
(mAECT) developed by Lumsden et al (1977) uses small volumes of 
blood (50 - 100 Jil) which is passed through a column of DE52 in a 
disposable 2 ml plastic syringe. The eluate is collected in a 
centrifuge tube made from a drawn-out sealed pasteur pipette. It 
is then centrifuged at 525 g for five minutes, and microscopy 
examination for trypanosomes is made at the sealed end as for
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Haematocrit Centrifugation technique (HCT).
Kimber (1984) reported on how to prepare buffer salts which 
can be stored at room temperature and reconstituted before using. 
He also showed that sterile prepared DEAE-Cellulose can be 
maintained at high temperatures for field use. The main set­
backs of the method are the costs and the provisions for the
availability of reagents for field use bearing in mind that 
different animal species require different buffer systems.
(c) Haematocrit Centrifugation Technique - HCT (Woo, 1969)
3 - 10 ml of blood is collected from the animal's jugular 
vein into a heparinised/EDTA vacutainer tube. After a gentle and 
thorough mixing, blood is drawn into a plain capillary tube 
(75 mm long, 1.2 - 1.5 mm internal diameter) up to three quarters 
of its length and its outside cleaned with a clean cloth or
tissue paper. One end of the capillary tube is sealed by a very
fine flame (without charring the blood column) or with
'cristaseal'. Following a 5 - 8  minutes centrifugation at 
12,000 rpm in a microhaematocrit centrifuge, the capillary tube 
is placed on a groove of a specially prepared microscope slide 
(two rectangular microscope slide pieces of 25 x 10 x 1.2 mm 
thick fixed with DPX on a clean microscope slide 1.5 mm apart). 
A cover slip is then put on and the interphase flooded with 
water. The buffer coat-plasma junction is then examined using a 
Leitz SM distance objective, a Zernicke condenser and periplan 
10 x eyepieces, or its equivalent.
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(d) Capillary Concentration Technique - CCT (Walker, 1972)
The method is designed to create a large differential
density between the erythrocytes and the trypanosomes to counter 
the tendency of T^ congolense to be retained amongst the red 
blood cells.
Equal volumes of blood and a strong hypertonic non-toxic 
medium (9% glycerol, 9% magnesium sulphate, 0.1% TRIS buffer, 
pH 8.0 - 8.2, and phenol red 1 : 100,000) are mixed and allowed 
to stand for a minimum of 15 minutes. Plain capillary tubes are 
used to draw the blood mixture and treated as for HCT.
(e) Darkground/Phase Contrast Buffy Coat Technique - DG 
(Murray et al, 1977)
A buffy coat zone is prepared in a micro-haematocrit 
capillary tube as for HCT. With a diamond pencil, the tube is 
cut 1 mm below the buffy coat to incorporate the uppermost layer 
of red cells, and 1 cm above to include some plasma. With an aid 
of a micro-haematocrit capillary tube holder, the contents are 
expressed on to a clean slide, mixed and covered with a 
22 x 22 mm coverslip. The preparation is examined using a phase 
contrast or darkground microscopy. Improved contrast can be 
obtained with a normal bright field microscope system with the 
condenser top out and/or the diaphragm closed to increase 
defraction.
Samples must be examined as soon as possible, at least 
within 4 - 6  hours after collection, otherwise the number of 
detectable trypanosomes falls off particularly with 
T. congolense.
36
The authors (Murray £t al, 1977) showed this method to be 
consistently more reliable than other standard parasitological 
techniques for detecting trypanosomes in cattle blood. The 
advantage DG offers of sensitivity, speed of detection, species 
identification, quantification of parasitaemia and PCV estimation 
all from one sample makes it the best of all parasitological 
methods for the diagnosis of African animal trypanosomiasis 
(Murray et al, 1979; Paris et al, 1982; Kalu et al, 1986).
Table 3
The Threshold Sensitivity (Trypanosome/ml Blood) of 
Concentration Methods and Animal Inoculation for the Detection 
of T^ congolense, T . vivax and T^ brucei (From Paris et al, 1982)
Method T^ congolense T . vivax T . brucei
HCT 6.25 X 103 1.25 X o
CO
5 X 102
m-AECT 2.5 X 103
inCM X 103 -
CCT 6 X 102 6 X 102 -
DG 2.5 X 102 5 X
CMOi—I 5 X 102
Mouse
Inoculation
- - 1.25 X
CMOr—l
Animal Inoculation
Laboratory rodents, particularly the readily available mice 
and rats have been used most frequently and they have been useful 
in revealing subpatent infection with Trypanozoon parasites in 
animals (Stephen, 1986).
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The susceptibility of laboratory rodents is increased by 
immunosuppression with cyclophosphamide (300 mg/kg) or 
irradiation. Up to 1 ml or 5 ml of infected blood is injected 
intraperitoneally into individual mice or rats respectively. 
These animals are then checked for trypanosomes by using tail 
blood at 2 - 3  day intervals up to 30 days post inoculation 
before being declared uninfected (negative).
Paris et al (1982) observed that inoculation of suspected 
infected blood into mice proved to be the most sensitive 
technique for the detection of T_;_ brucei. However, the results 
vary depending on the phase of parasitaemia and the ratio of 
infective to non-infective forms present in the donor's blood. 
The value of inoculation of suspected T_^  congolense or T^ vivax 
infected blood/material is more limited as not all field isolates 
become established in rodents.
Stephen (1986) drew attention to scientists to further 
examine/study an unpublished technique employed by a technical 
assistant in a Nigerian laboratory. In the technique, 2 - 3  mis 
of heparinised blood is injected intraperitoneally into a 
laboratory-bred white rat. The hair coat is shaved off to allow 
the spleen to be easily seen. 10 - 15 minutes post inoculation, 
a splenic puncture is made through the thin body wall and the 
aspirate is examined as for wet or stained blood films. He 
observed that the originator of this technique often enough 
discovered trypanosomes when other rapid tests were negative.
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Serological Tests
The preceding parasitological techniques rely on the 
demonstration of the trypanosomes in the host tissues 
particularly the blood, and this is possible during the acute 
stages of the disease when large numbers of the parasites are in 
circulation. However, during the early stages of infection or in 
chronic disease when the parasitaemias are low and sporadic, it 
is usually difficult to detect the trypanosomes in the blood. In 
such cases, diagnosis of infections with T^ vivax and some 
isolates of T^ congolense is further hampered by lack of 
infectivity for laboratory rodents. In such situations, 
serological tests can be very useful for diagnosis and
particularly when conducting large scale trypanosomiasis surveys 
in which detailed microscopic examinations may not be possible.
Serological tests are based on the detection of antibodies 
against trypanosome antigens and/or trypanosome antigens in 
serum. Antibody detection tests have been used for the detection 
of trypanosome infected animals, and have been able to diagnose 
the disease as early as seven days post infection. However,
various studies in laboratory animals and naturally or 
experimentally infected livestock showed that antibody levels 
decline slowly and remain higher than pre-infection levels
several weeks after the parasites have been eliminated following 
trypanocidal treatment (Woo and Soltys, 1972; Staak and Lohding, 
1979; Luckins, 1977; Luckins and Mehlitz, 1978; Luckins et al, 
1978; 1979).
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The persistence of antibodies against trypanosomes in serum 
complicates the evaluation of the infection status of individual 
animals as it is difficult to differentiate between a current and 
past infection. As it has been argued by Urquhart and Holmes
(1987), antibody detection tests seem to be more valuable in 
assessing the distribution and incidence of infection in areas 
where the disease is uncommon or suspected, and in screening of 
potential experimental animals destined for trypanosomiasis 
research.
Tests which demonstrate circulating trypanosome specific 
antigens or products in the host enables active infections to be 
diagnosed and appear to offer the desired sensitivity and 
specificity; and they can also be useful in the evaluation of 
trypanocidal treatments (Rae and Luckins, 1984; Nantulya et al, 
1987; Liu and Pearson, 1987; Liu et al, 1988; Nantulya and 
Lindquist, 1989).
In their experiments with rabbits and goats, Rae and Luckins 
(1984) demonstrated that, circulating antigens can be detectable 
in serum as early as 4 - 14 days post-infection and disappear 
within ten days after trypanocidal treatment. In cattle, 
Nantulya and Lindquist (1989) detected circulating trypanosomal 
antigens between 10 - 12 days post-infection with T^ congolense 
and T^ vivax; and 8 - 1 4  days with T^ brucei infected animals. 
The antigens were cleared from the blood within two weeks 
following Berenil treatment in vivax and congolense
infected cattle, but clearance was slower and more variable in 
T. brucei infections.
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Nantulya et al (1987) cautioned that, at certain stages of 
infection, an antigen-antibody equilibrium in tissue fluids may 
shift to the extent that, free antigens may be undetectable. 
Therefore, assays for both circulating antigens and antibodies 
should be developed.
Immunodiagnostic tests fall mainly in two categories, that 
is, in vitro and in vivo tests.
In Vitro Tests
These assess the outcome of antigen-antibody interaction 
directly. The tests which have been used in the diagnosis of 
African animal trypanosomiasis include; enzyme immunoassays, 
fluorescent antibody tests, precipitation reactions, 
haemagglutination reactions, complement fixation test and radio­
immunoassay.
Enzyme Immunoassays (EIA)
Enzyme immunoassays are qualitative and quantitative 
immunological procedures in which the extent of antibody-antigen 
reaction is evaluated by enzyme measurements (Avrameas, 1981).
They take advantage of and make use of the biological properties 
of antibodies and enzymes (Kurstak, 1986).
The general principle employed in EIA is that an appropriate 
enzyme is conjugated to one of the immunoreactants, that is, 
antigen (Ag) or antibody (Ab). Following an immunological 
reaction (Ag-Ab interaction), a substrate is added and the 
substrate-product enzyme conversion is determined. The product 
concentration indicates how much enzyme-labelled immunoreactant
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has been incorporated in the immunological reaction complex.
Therefore, EIA can be employed to detect and quantify antigens
and antibodies in body fluids (Avrameas, 1981; Kurstak, 1986).
The positive advantages EIA have over other serological
tests include the easiness of performing the tests and reading of 
results; adaptability to simple tests and to automation 
(detection systems range from visual to photometric with
coloured, fluorescent or luminescent substrates); use of cheap 
and stable reagents with a long shelf life, and have minimal risk 
of contamination thus free from limiting legislation. EIA are 
suitable under field conditions and particularly for sero- 
prevalence surveys of large populations (Anon, 1976; Voller 
et al, 1979; Avrameas, 1981; Kurstak, 1986).
There are basically two types of EIA, homogenous and 
heterogenous, and in each type the tests can either be 
competitive or non-competitive.
(a) Homogenous EIA
These assays are performed in solution and are most often 
used for the detection of small compounds (haptens). They are 
based on the principle that the enzyme activity is altered during 
the immunological reaction of the labelled reagent ( Vollier 
et al , 1976; Kurstak, 1986).
(b) Heterogenous EIA
These assays are particularly used in the detection of large 
molecules such as infections agents. They are based on the 
principle that one immunoreactant (antigen or antibody) can be 
immobilised by being passively adsorbed on to a solid phase
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without losing its reactivity, and the complementary 
immunoreactant can be conjugated to an enzyme in such a way that 
it still retains both its immunoreactivity and enzymatic 
reactivity. It is essential in these assays that non-specific 
binding is avoided and free immunoreactants are separated from 
the bound (Voller et al, 1979; Kurstak, 1986).
Heterogenous EIA, especially Enzyme Linked Immunosorbent 
Assay (ELISA) has attracted most attention and has been employed 
in the diagnosis of trypanosomiasis (Voller et al, 1979; Luckins, 
1977; Sillayo et al, 1980; Townsend et al, 1982; Duf fus, 1982; 
Rae and Luckins, 1984; Liu and Pearson, 1987; Nantulya et al, 
1987; Liu et al, 1988; Nantulya and Lindquist, 1989).
Fluorescent Antibody Tests (FAT)
Unlike in EIA, these tests employ antibodies labelled with a 
fluorochrome. The commonly used fluorochromes are fluorescein 
isothiocyanate (FITC) and tetramethyl rhodamine isothiocyanate 
(TRITC). After an immunological reaction, the antigen-antibody 
(Ag-Ab) complex is observed under ultra-violet stimulus using a 
fluorescence microscope. Two types of FA staining are 
distinguished, that is, a direct technique and an indirect 
technique.
Direct FAT
In this technique, the fluorochrome is linked to an antigen- 
specific primary antibody.
Trypanosomes are made to adhere to a glass slide and then 
coated with a specific fluorochrome labelled primary antibody. 
If the antibody combines with the trypanosome (antigen), it
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remains attached even after washing of the preparation and the 
trypanosomes will be seen to fluoresce under a UV-microscope 
(Stephen, 1986) . These methods are suitable in identifying 
unknown antigens using antigen specific antisera.
Indirect FAT (IFAT)
For this technique, the antigen adhered to a glass slide is 
first located with an unlabelled primary antibody in a test
sample (serum) and a labelled second antibody (anti-species IgG) 
is used to detect the Ag-Ab complex.
IFAT also referred to as "sandwich methods" are more
sensitive than the direct method (Stephen, 1986). The antigen
used in IFAT is simpler to prepare than in ELISA; usually
consisting of smears of blood stream trypanosome forms from a
suitable animal either unfixed or commonly fixed in acetone, and 
they can be stored desiccated at -20°C. The test sera can be 
applied as a spot dilution or as a series of dilutions and the
end-point is judged by the intensity of the fluorescence. The
judgement of the end-point needs considerable experience and may 
vary from one investigator to another, hence making the
interpretation of the results subjective (Anon, 1976).
IFAT has been used in the diagnosis of trypanosomiasis, but 
it has little value for individual animals and finds its greatest 
usefulness when employed on a herd basis (Stephen, 1986). IFAT 
has been found to be a highly sensitive method in detection of 
trypanosomal antibodies and compares favourably with ELISA. The 
ability of IFAT to distinguish between infections caused by the 
subgenera of salivarian trypanosomes, though controversial, it is
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generally difficult (Wilson, 1969; Zwart et al, 1973; Luckins, 
1977; Luckins and Mehlitz, 1978; Wells et al, 1982; Stephen, 
1986). Since antibody levels in trypanosomiasis do not reach 
detectable levels for a few days after infection, early 
infections can be missed; while the persistent high antibody 
levels following trypanocidal treatment also poses a problem in 
assessment of infections. False positives due to T^ theileri 
antibodies may be encountered, however they can be eliminated by 
suitable dilution (1 : 160) of the test sera (Zwart et al, 1973).
It is virtually impossible to mechanise IFAT, thus fewer 
samples can be screened per day. Also, the use of expensive, 
electric current dependent UV-microscope makes the relative cost 
per test to be very high and renders it unsuitable for use under 
field conditions (Anon, 1976).
Complement Fixation Test (CFT)
This is essentially a two phase test based on the principle 
that when an antigen reacts with a specific antibody in presence 
of complement (usually in added guinea pig serum), the 
complement is fixed to the immunoreactants and loses its ability 
to act further. A second system is an indicator system usually 
consisting of sheep red blood cells and anti-sheep red blood cell 
serum. Following addition of the indicator, haemolysis of the 
sheep red cells will indicate the presence of free complement, 
that is, the antigen and antibody did not combine and therefore 
the test is negative. The test is positive when there is no 
haemolysis (Stephen, 1986).
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There have been claims that CFT compares in sensitivity and 
specificity with IFAT in the diagnosis of experimental 
T . congolense infections in cattle and it was easier to read than 
IFAT. Staak and Lohding's (1979) experiment in cattle showed 
that the specificity of the result after the first infection was 
low in T^ congolense, fair in T^ brucei and high in T^ _ vivax 
infected cattle. Reinfection with the same trypanosome species 
resulted in high specificity of CF results in all cases. 
Following trypanocidal treatment, the fastest drop in CF antibody 
titres was observed in T^ _ congolense cases followed by T^ brucei 
cases, while persistence over prolonged periods (more than 56 
days) was observed in T^ vivax infected animals.
Due to the cumbersome nature of the test, it has not gained 
any routine use in the diagnosis of African animal 
trypanosomiasis.
Radio-immunoassay (RIA)
Solid-phase RIA can be carried out in a similar way as ELISA 
using intact parasites centrifuged then fixed on microtitre 
plates. However, RIA has not been employed as a diagnostic test 
in trypanosomiasis due to the complicated nature of using 
radioisotopes in labelling of the immuno re agents which does not 
only present a health hazard but the labelled reagents have also 
a short shelf life. Also, the expensive, electrical dependent 
equipment needed makes the test unsuitable and not feasible under 
field conditions.
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Haemagglutination Reactions
These rely on the observation that various inert particles 
with soluble antigenic material adsorbed to their surface 
agglutinates in the presence of an appropriate antibody. 
Therefore, red blood cells which are treated, for example, with 
tannic acid, then coated with trypanosome antigens will
agglutinate in an observable manner in the presence of a
homologous antibody. Haemagglutination tests are sensitive,
however, the haemagglutination inhibition reaction is even more 
sensitive (Stephen, 1986). Woo and Soltys (1972) found in 
experimentally T^ rhodesiense infected rabbits and T^ _ brucei 
infected sheep that indirect haemagglutination test may be a
simple and a reliable serodiagnostic test.
For the diagnosis of trypanosomiasis in man and animals, 
various tests have been tried, such as a red cell adhesion, 
trypanolytic reactions, charcoal agglutination, latex 
agglutination, capillary tube agglutination, immuno-conglutinin 
level etc., however they all detect antibody and in most cases 
they lack the necessary specificity required, particularly where 
multiple infections occur. Therefore, they have largely remained 
of value, in research/experimental procedures (Stephen, 1986).
In Vivo Tests
The result of antigen-antibody interaction in these tests 
are assessed by inoculation of the reactants into laboratory 
rodents. One of such tests is "Neutralisation of Infectivity" 
described by Lumsden et al (1963), however it has never gained 
any practical routine use as a diagnostic test in African animal
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trypanosomiasis.
CONTROL OF AFRICAN ANIMAL TRYPANOSOMIASIS
Several control measures have been developed and used over 
the past years and others are still under experimentation. All 
in all, the control methods can be grouped into two main 
categories; control of trypanosomiasis in the vertebrate host, 
and the control of the vectors, tsetse flies.
Control of Trypanosomiasis in the Vertebrate Host
Chemotherapy and Chemoprophylaxis
This is discussed extensively in the next section.
Use of Trypanotolerant Animals
Trypanotolerance or reduced susceptibility to African 
trypanosomiasis has been observed in some breeds of cattle, sheep 
and goats in Africa. It has been suggested that it results from 
a complex mixture of innate non-specific and acquired specific 
immune mechanisms mediated by physiological, biochemical and 
immunological factors (Vickerman and Barry, 1982).
The resistance to trypanosomiasis has been concluded to be 
genetic in nature as it has apparently been produced by natural 
selection, and therefore there is a possibility of breeding for 
tolerance (Finelle, 1980; Murray et al, 1981; Murray and Trail, 
1984).
Reports by ILCA (1979) and Murray et al (1981) show that, 
despite the relative small size of the trypanotolerant breeds, 
they can survive and be productive in trypanosomiasis endemic
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areas where Zebu perish. Those living under low or zero tsetse 
challenge are at least as productive as the other less tolerant 
breeds. The exploitation of trypanotolerant breeds offers 
therefore, one of the most important strategies to the control of 
African animal trypanosomiasis. However such breeds are largely 
restricted to West Africa.
Vaccination
It is not yet feasible to vaccinate animals against 
trypanosomiasis and no encouraging results from attempts to 
induce immunological protection under field conditions have been 
reported. Researchers have been compiling a "wardrobe" of all 
possible variations of glycoproteins. However, even though such 
a collection called a serodeme could be identified, synthesised 
and injected into an animal, it is unlikely to be effective since 
the animal's immune system would not respond adequately to so 
many different antigens.
Vaccination may be possible only after knowing how the 
process of antigenic variation takes place and how to disrupt it. 
Extension of studies such as those of Tetley et al (1981) and 
Jenni and Brun (1981), may be helpful.
Vector Control
Vector control is one of the important measures used to 
eliminate trypanosomiasis from an area. Different methods have 
been applied, however total elimination of tsetse has always been 
difficult to achieve due to the re-invasion of the treated zones 
by tsetse from adjacent infestations or by recrudescence of small
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foci that have been difficult to eliminate. This has also been 
aggravated by the absence of well defined area development 
projects (Finelle, 1980).
The methods employed for controlling the vectors can be 
grouped into two main categories, viz. biological and chemical 
control.
Biological Control
This involves methods such as the use of predators, 
parasites, pathogens, release of sterile males, cytogenetical 
manipulations (genetical control) and destruction of tsetse 
habitat (ecological control).
Bush clearing to deprive the vectors of shade, moisture and 
breeding sites, which are essential for its survival, replaced 
after the second world war, the ill-conceived, if well meaning 
massacre of wildlife (Allsopp et al, 1985). Bush clearing has 
been extensively used and may still be useful, however the labour 
costs involved and the risk of soil erosion precludes its 
application on a large scale.
Promising results have been obtained with applied research 
on the release of sterile males (Sterile Insect Techniques - SIT) 
in Tanzania, Nigeria and Zimbabwe, however its effectiveness and 
economic implications have not yet been fully determined 
(Finelle, 1980; House, 1982; Takken et al 1986; Brandi, 1988).
The use of predators, parasites and pathogens of the 
vector's puparial and adult stages are possibilities which have 
been attempted but are yet to be put into practice (Nantulya,
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1986)
Chemical Control
The use of insecticides still remains as the most reliable 
and practical alternative for large scale tsetse control 
(Finelle, 1980; Allsopp, 1984). Insecticides have been in use 
since the 1940s following the successful early trials with DDT 
and other chlorinated hydrocarbons around Lake Victoria in 
Tanzania, and later on in Kenya, Uganda, Nigeria and Zimbabwe by 
ground spraying using pressurised knapsack sprayers (Allsopp 
et al, 1985).
The low dosage aerosal technique which proved highly 
successful and environmentally acceptable was later adopted. 
Sequential aerial spraying became widely established as an 
effective technique for rapid and extensive control of tsetse 
(Allsopp et al, 1985); and it is considered to be more economical 
than the trapping of tsetse and SIT in long term, for programmes 
covering large areas (Brandi, 1988). While the application of 
conventional ground spraying is hampered by high rainfall, aerial 
spraying has its own logistic problems. The spraying at night to 
overcome meteorological conditions (convection and high wind) 
results in the inability to deposit the insecticide effectively 
on the ground in hilly areas and on tall forest trees. Aerosol 
spraying also demands efficient ground support and expensive, 
sophisticated equipment (Allsopp et al, 1985).
Simple, cheaper and environmentally more acceptable methods 
came into use following the appearance of the "Challier- 
Laveissiere biconical trap" in 1973. Traps baited with acetone
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or carbon dioxide and 1-octen-3-ol, and impregnated with a 
pyrethroid insecticide, detamethrin, have been in use with very 
promising successes in Zimbabwe, Malawi, Zambia, Cote d'ivoire 
and Nigeria (Allsopp et al, 1985; Brandi, 1988). Takken et al 
(1986) found that insecticide impregnated targets adequately 
controlled tsetse population in marginal habitats in central 
Nigeria, and the same targets were also efficient barriers in 
preventing reinvasion of the treated area.
As it has been argued by Allsopp (1984) , an integrated 
insecticidal approach combining the benefits of various chemical, 
and possibly non-chemical control methods, could provide a 
solution to the persistent tsetse and trypanosomiasis problems in 
Africa.
CHEMOTHERAPY AND CHEMOPROPHYLAXIS OF AFRICAN ANIMAL 
TRYPANOSOMIASIS
Chemotherapy and chemoprophylaxis are of particular 
importance as practicable means of combating trypanosome 
infections in animals. Trypanocides are widely used and it is 
estimated that, over 25 million treatments are carried out 
annually in Africa, the majority being for the treatment and 
control of bovine trypanosomiasis (Tacher, 1982). The 
trypanocides that have been developed and used for curative and 
prophylactic purposes for the control of animal trypanosomiasis 
are categorised in the following text.
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Figure 1. Suramin Sodium
(CH3S04)2
Figure 2. Quinapyramine Dimethosulphate
Arsenic Compounds
These were in use as early as the middle of the 19th Century 
to combat trypanosomiasis in Africa, however they are no longer 
of significance in animal trypanosomiasis (Ruchel, 1975).
Antimony Compounds
Potassium-antimony tartate (tartar emetic) or its sodium 
analogue was first shown by Plimmer and Thomson in 1908 to be 
able to eliminate infections with T^ brucei and T_^  evansi in 
laboratory rodents. Due to its severe tissue reaction, it was 
administered intravenously in cattle at a dosage of 1.0 - 1.5 g 
in a 5% aqueous solution and sometimes repeated at daily or 
weekly intervals. However, it was later proved to be effective 
only against T^ vivax and T^ congolense but not T^ brucei 
infections in cattle. Though the drug caused about 6% mortality 
due to its toxicity in treated cattle, it was used on a large 
scale in Africa, and it continued to be in use in some areas 
until the early fifties (Leach and Roberts, 1981).
R
Pentasodium antimonybiscatechol-3,5 disulphate (Antimosan , 
Bayer Company) was used in 6.3% tissue-isotonic, almost neutral 
solution to treat T\_ congolense and T^ _ vivax infections in cattle 
(Ruchel, 1975).
Sulphonated Naphthylamine Compounds
R R RSuramin (Bayer 205 , Antrypol , Moranyl ) was developed in
Germany between 1914-1918 and became available in 1920. Its
development began with the synthetic cotton dye, Congo Red, from
which the first metal-free trypanocides, trypan red and trypan
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blue emerged.
More active and colourless compounds were produced by 
substituting urea for benzidine as the central link for the two 
halves of the symmetrical polycyclic dye molecule.
Suramin (Figure 1) was shown to be effective against 
experimental infections with equiperdum and naturally 
occurring 1\_ evansi infections in camels. To date, suramin has 
remained as the drug of choice in the treatment of Trypanozoon 
infections in equines and evansi infections in camels as it is 
less toxic in these species than quinapyramine. It is given 
intravenously as it can cause severe local reactions when 
administered by other routes (Leach and Roberts, 1981).
Quinoline and Fhenanthridine Compounds
The development of the drugs contained in this group 
followed the findings of the trypanocidal activity in acridine 
dye, notably acriflavine. Dissection of the linear 3-ring 
molecular structure gave rise to compounds consisting of the 2- 
ring portion containing a nitrogen atom (i.e. quinoline), or of 
the isometric non-linear 3-ring phenanthridine derivatives which 
all proved to be trypanocidal.
4-aminoquinoline derivative, surfen-C, showed marked
activity against T^ _ congolense. Nevertheless, the field trials
of the 1930s in Africa led to its unacceptability due to its
toxic reactions when administered either intravenously,
intramuscularly or subcutaneously. Further developments of this
drug subsequently led to the synthesis in the early fifties of
R
quinapyramines (Antrycide ).
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Quinapyramine dimethosulphate (Figure 2) is a yellow powder 
with up to 33% solubility in water. It is active against 
T . congolense, T . vivax and T_;_ brucei, and is used for curative 
purposes in all domestic animals at a recommended dose of
4.4 mg/kg bodyweight (BW) subcutaneously. Sometimes, it may 
provoke toxic reactions particularly in equines, nonetheless this 
may be avoided by dividing the dose into two halves and giving 
them at 5 - 6 hours interval (Ruchel, 1975; Leach and Roberts, 
1981).
Quinapyramine chloride is sparingly soluble in water, and
subcutaneous administration was shown to result in a formation of
a depot at the injection site with a slow release of the drug.
Thus, though the trypanocidal levels are reached, they are too
low for curative purposes. A mixture containing three parts by
weight of the quinapyramine dimethosulphate and four parts by
weight of quinapyramine chloride was made and marketed as
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Antrycide Prosalt , with a recommended dosage of 11 mg/kg giving 
a 5 mg/kg quinapyramine dimethosulphate. Subsequently a revised 
formulation (RF) in which the quinapyramine chloride is halved 
and the recommended dosage reduced to 7.4 mg/kg BW was introduced 
and proved to be equally effective and less costly. In this 
mixture the therapeutic and prophylactic actions and effects of 
the two basic preparations are combined, providing a 2 - 4 month 
protection (Ruchel, 1975; Leach and Roberts, 1981; Finelle, 
1983b).
Phenidium chloride was the first in the aminophenanthridine 
series to be used in the treatment of animal trypanosomiasis in
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1931, and its effectiveness against T_^  congolense and T\_ vivax 
infections in cattle was reported by Browning et al (1938). 
However, due to its low solubility and a narrow therapeutic 
index, attention was directed to other phenanthridines with an 
eventual development of dimidium bromide.
Dimidium bromide proved to be effective against 
T . congolense and able to eliminate the majority of infections at 
a dosage of 1 mg/kg BW subcutaneously. The drug was used for 
mass treatment campaigns in East and Central Africa, however by 
1952 drug resistance became widespread and the use of higher 
doses resulted in severe toxicity exhibited by local reactions 
and photosensitisation after treatments in cattle at 1 - 2 mg/kg 
BW subcutaneously (Evans, 1948).
D
Homidium bromide (Ethidium , CAMCO) was developed by 
substituting an ethyl for a methyl group on the quaternary 
heteroatom of dimidium (Watkins and Wolfe, 1952), and the drug 
proved to be as equally effective as dimidium against T\_ vivax 
and congolense infections at 1 mg/kg BW intramuscularly, and
less toxic. Ethidium is an almost odourless, dark purple, 
crystalline or amorphous powder with a little solubility in cold 
water (1 : 29) increasing to 1 : 10 in hot water. The 
preparation has mainly a curative effect, and overdosages result 
in damage to the liver, oedemata or even death (Ruchel, 1975; 
Leach and Roberts, 1981).
D
Homidium chloride (Novidium , RMB Animal Health Ltd.) is 
equally active therap^itically at a dose of 1 mg/kg BW 
intramuscularly and is soluble in cold water. Photosensitisation
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of the skin is possible with light-coloured animals or local
swellings may occur (Ruchel, 1975). Homidium compounds 
(Figure 3) have been shown to have a selective effect on vivax 
infections in cattle and have also been used with success in 
treating T_;_ vivax infections in the horse. The trypanocidal 
action of homidium compounds is related to the ability of the 
drug to bind with trypanosome's kinetoplast DNA (Wagner, 1971; 
Henderson et al, 1977).
D
Pyrithidium bromide (Prothidium , May and Baker Ltd.) was 
produced by the substitution of the pyrimidyl moiety of
quinapyramine for a hydrogen of the 7-amino group of 2,7-diamino- 
9-p-aminophenyl-10-methyl phenanthridium chloride (Watkins and 
Woolfe, 1956). The drug (Figure 4) is an odourless, red or
reddish purple powder. Solutions of 2% are made by dissolving
the drug in boiling water, and when used, have been shown to
eliminate T^ _ congolense infections in the field when given at
0.2 - 0.4 mg/kg BW intramuscularly or subcutaneous ly (Whiteside, 
1960). Intramuscular injections of 2.0 mg/kg BW have been shown
to give protection in cattle against T^ vivax and T^ congolense
for 2 - 4  months (Finelle, 1983b).
Wragg et al (1958), developed metamidiura by following the 
same principles used in the synthesis of pyrithidium. They 
combined the diazotized p-aminobenzamide moiety of the 
diminazine molecule with homidium chloride in the presence of 
sodium acetate giving rise to two isomers both of which have 
trypanocidal action. It was later revealed that the more active 
of the two products, that is, metamidium, was itself a mixture of
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Br' or Cl"
Figure 3. Homidium Bromide or Chloride
N\>s N
H ^ C
l Br’ ]2
Figure 4. Pyrithidium Bromide
[Cl‘ ] HCI
Figure 5. Isometamidium Chloride
two isomers. Berg (1960; 1963) clarified the structure of the
soluble, highly active red isomer and was able to isolate it in 
sufficient quantities for field trials; it was named
D
isometamidium (Samorin , RMB Animal Health Ltd.).
Isometamidium (Figure 5) was first marketed in 1961 and it 
was recommended to be administered intramuscularly at a dose of 
0.5 mg/kg BW for curative purposes of sensitive strains, 1 -
2 mg/kg BW for drug resistant strains and 2 mg/kg BW for 
prophylaxis.
Intramuscular injection of isometamidium can cause severe 
local reactions and extensive fibrosis (Boyt, 1971; Finelle, 
1983a). Kinabo and Bogan (1988d) showed that the necrotic tissue 
at the injection site to be well defined, ovoid in shape 
measuring about 8 cm in length, with a cross section diameter of
2.5 cm at the middle and surrounded by a markedly oederaatous 
muscular tissue. At six weeks following drug administration, the 
necrotic tissue was surrounded by a dense large mass of fibrous 
tissue, and despite the lesion appearing to contract grossly, 
microscopically the lesion was similar to that observed at three 
weeks.
Finelle (1983a) advised dividing the dose so that the
injection volume does not exceed 15 ml per one injection site. 
Toure (1973a) showed that intravenous doses of 0.5 mg/kg BW can
be well tolerated by goats and cattle. Intravenous injection can
be an alternative method of isometamidium administration provided 
that the injection is made slowly, leakage to subcutaneous tissue 
and solutions of high strength (more than 2% w/v aqueous)
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avoided, and the correct dosage made (Toure, 1973b; Kalu, 1983; 
Kalu et al, 1983; Ali and Hassan, 1984; Dowler et al, 1989).
Isometamidium, like homidium, displays antitumour effects, 
apparently related to the inhibition of nucleic acid synthesis 
due to the drugs binding to DNA (Wagner, 1971; Henderson et al, 
1977) . Kinabo and Bogan (1987) reported that isometamidium has a 
higher affinity for DNA as compared to homidium. The interaction 
of isometamidium with anionic lipids may also account for some of 
its actions as lipid requirements of trypanosomes are considered 
to be largely exogenous and incorporated into phospholipids upon 
uptake. . It is probable that isometamidium interferes with the 
uptake mechanism or the intermediary metabolic steps.
Aromatic Diamidines
Diminazine aceturate (Berenil , Farbwerke Hoechst A.G.) was 
developed from surfen C as detailed by Jensch (1958). The drug 
is an odourless, yellow powder, with a solubility of 1:14 in cold 
water (20°C) and only slightly soluble in alcohol, ether and 
chloroform. Solution can be used for up to 10 - 15 days when 
stored at room temperature.
Berenil is administered intramuscularly at a recommended 
dose of 3.5 mg/kg BW. This has been shown to eliminate
infections with T^ vivax and T_;_ congolense, but a dose of
5 mg/kg BW is required to eliminate infections with T^ brucei. 
The drug is also effective against Babesia spp (Leach and 
Roberts, 1981). Berenil is well tolerated by most domestic
animals, for example in cattle, Fairclough (1963) showed that
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doses of up to 21 mg/kg BW could safely be given.
Almost all of a parenterally administered dose of Berenil is 
rapidly excreted through the kidneys and cleared from blood 
within 24 hours after injection, this makes the drug unsuitable 
for prophylactic use. The characteristic of quick clearance has 
been thought to reduce the risk of development of resistance. 
However, resistance to Berenil has been observed since 1967 in 
T . vivax and T^ _ congolense infections, notably in the Central 
African Republic, Chad, Nigeria, Kenya and Uganda (Finelle, 
1983a) and recently reported in Tanzania (Mbwambo et al, 1988). 
Finelle (1983a) advised the use of another trypanocide such as 
isometamidium when resistance occurs rather than increasing the 
dosage of Berenil.
A summary of the aforementioned trypanocides currently 
employed for the treatment of animal trypanosomiasis is given in 
Table 4, whereas Table 5 shows the drugs that are used for 
prophylactic purposes.
Isometamidium chloride is currently the only available drug 
with both curative and prophylactic activity against salivarian 
trypanosomes in domestic animals (Kinabo, 1988a). Strict 
adherence to the treatment regimens so as to avoid the 
development of drug resistance is essential. This has not been 
helped by fluctuations in availability of the drugs in Africa. 
Moreover, chemoprophylaxis has been limited under conditions of 
traditional animal production. The problems associated with 
chemotherapy and chemoprophylaxis of African animal 
trypanosomiasis, namely, pharmacological (range of drugs
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available, drug resistance, toxicity, duration of prophylaxis) 
and logistical and financial problems (communications and 
facilities, personnel, education, finance, political structure) 
have been well discussed by Holmes and Scott (1982).
In tsetse infested areas, chemoprophylaxis using 
isometamidium chloride has been shown to be economical and 
effective method of control of animal trypanosomiasis (Ford and 
Blaser, 1971; Wilson et al, 1975; 1976; Logan et al, 1979; Owero 
Wafula and Mayende, 1979; Morrison et al, 1981; Holmes and Scott, 
1982; Trail et al, 1985; Dowler et al, 1989).
The precise duration of prophylaxis with isometamidium 
chloride is still debatable and varies widely. The factors which 
may influence the duration of prophylaxis have been thought to 
include drug dosage, stress and plane of nutrition, concurrent 
diseases, breed susceptibility and/or tolerance, level of 
parasite challenge, trypanosome species and the host immune 
system (Toure, 1973b; Njogu et al, 1985; Whitelaw et al, 1986; 
Peregrine et al, 1988; Jibbo et al, 1988; Ogunyemi and Ilemobade, 
1989). However, most of these factors have not been thoroughly 
investigated.
It can be drawn from Table 6 that higher drug dosages give a
longer period of prophylaxis than lower dosages. This is
supported by the work of Peregrine et al (1988) using
T. congolense metacyclics, who demonstrated a direct relationship 
between drug dosage and the duration of chemoprophylaxis. It has 
been suggested by Whitelaw et al (1986) , drug residues at the 
level of the skin may play an important role in the mode of
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action of isometamidium chloride. It is possible that the higher 
the dosage, the higher is the amount of drug in depot tissues; 
nonetheless, other factors such as the injection site and/or the 
mode of administration, the degree of tissue reaction at the 
injection site and physical exercise of the animal may also be 
important. Since dosages higher than 1.0 mg/kg BW are normally 
not recommended, formulations which have shown to provide longer 
duration of prophylaxis without adverse effects to the animal, 
such as isometamidium-dextran sulphate complex (Aliu and Sannusi, 
1979) or liposomal formulation of isometamidium chloride (Fluck 
and Hopkins, 1987) may be useful in the future.
In contrast to laboratory or well controlled experimental
conditions, animals in the field are subjected to various 
stresses and periods of poor nutrition. The relationships 
between such stresses or varying levels of nutrition and the 
duration of prophylaxis have not been fully investigated.
In their experiment (Whitelaw et al, 1986) , no anti- 
trypanosome antibodies were detected in the animals which 
successfully resisted challenge and they concluded that antigenic 
priming of the immune system does not occur during 
chemoprophylaxis. Peregrine et al (1988) also found that
antibodies to metacyclics did not appear in any of the cattle as
long as chemoprophylaxis was effective, and in a group 
(challenged with 5 x 10^ iji vitro derived metacyclic
trypanosomes) where low antibody titres were found, they proved 
to be non-protective. They concluded that antibody is unlikely 
to play any significant protective role in animals maintained by
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a cheraoprophylactic regime with isometamidium.
Comparative studies pertaining to the relative duration of 
prophylaxis by isometamidium against T_;_ vivax and T_;_ congolense 
in cattle under controlled conditions are lacking. The results 
obtained by various studies under laboratory conditions (Table 7) 
indicate that the duration of prophylaxis may be shorter in 
T . vivax than in T_^  congolense infections at a dose of 
0.5 mg/kg BW; however, at 1.0 mg/kg BW the duration is similar.
Earlier studies by Whiteside (1962), Trail et al (1985) and 
Jibbo et al (1988) appear to indicate that the duration of 
chemoprophylaxis with isometamidium was reduced in areas of high 
tsetse challenge. However, they lack the evidence of an existing 
relationship between high tsetse density and high trypanosomiasis 
risk or level of challenge. It was found out by Peregrine et al 
(1988) that the duration of prophylaxis afforded by isometamidium 
in the two T^ congolense serodemes examined were the same, 
irrespective of the method or weight of challenge. In the same 
experiment, they showed that when isometamidium is used to treat 
an existing infection in cattle, it offers the same degree of 
chemoprophylactic activity against an unrelated serodeme, thus a 
concurrent infection does not appear to affect the duration of 
prophylaxis.
In principle, it would be advisable to make preliminary 
trials in order to determine the treatment rate per year in a 
given locality, and Berenil should be used as a "sanitive" if 
relapses occur before a seeond prophylactic dose of isometamidium 
is due (Finelle, 1983b).
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Table 7
The Duration of Isometamidium Prophylaxis Against Different 
Trypanosome Species in Cattle tinder Laboratory Conditions
Trypanosome
Drug 
Dosage 
(mg/kg BW)
Duration
(Months) Reference
T . vivax 0.5 2 Aliu and Sannusi (1979)
T. vivax (IL2968) 0.5 2 ILRAD (1987)
T. vivax (IL2969) 0.5 1 ILRAD (1987)
T. congolense 0.5 3 Peregrine et al (1988)
T . vivax 1.0 4 Toro et al (1983)
T. congolense 1.0 4 Peregrine et al (1988)
T. congolense 1.0 5 Whitelaw et al (1986)
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All in all, as advised by Lee and Maurice (1983), the
treatment with prophylactic drugs should be carried out; firstly, 
when animals are to be exposed to tsetse challenge for a specific 
and limited period of time, which is shorter than the protective 
period of the drug; and secondly, when the animals are stationary 
(i.e. not nomadic) and are available throughout the year for 
regular inspection and treatment.
Drug Resistance in Chemotherapy and Chemoprophylaxis
The extensive use of trypanocidal drugs for the treatment 
and control of African animal trypanosomiasis has resulted in the 
appearance of drug-resistant trypanosomes in many parts of Africa 
(Evans, 1948; Whiteside, 1961; Jones-Davies, 1967; Anon, 1979; 
Gitatha, 1979; Morrison et al, 1981; Finelle, 1983a; Lee and
Maurice, 1983; Mbwambo et al, 1988). The problem of drug
resistance became so prevalent in some areas, for example,
Nigeria (Na'Isa, 1967) so as to warrant the withdrawal of
homidium chloride (Novidium) from general use. Drug resistance 
may have also been advocated by having a limited number of
effective trypanocides considering that no new drugs have been 
brought to market for more than 30 years.
Under field conditions, drug resistance refers usually to 
the failure to cure an infection with a normal curative dose of
the drug concerned. This is of practical importance as the
curative dose is near the maximum tolerated dose with many 
trypanocidal drugs (Leach and Roberts, 1981). The resistance can 
either be natural or acquired/developed.
68
Natural resistance of a trypanosome strain or species to a 
drug is that variation in drug sensitivity shown by trypanosomes 
that is not dependent on previous exposure to the particular 
drug. For example, homidium is more effective against T_;_ vivax 
than against congolense; whereas West African strains of
T . vivax have a higher level of natural resistance to diminazine 
than T^ _ congolense (Leach and Roberts, 1981).
Development of drug resistance in the field is thought to
occur as a result of underdosing, whereby the concentration of
the trypanocide in the animal's body is below the effective level 
to ensure destruction of the trypanosomes. This can result from 
frank underdosing (incorrect dosage) particularly in mass 
treatments, irregular prophylactic regimes or stopping the use of 
a trypanocide while the animals are still at risk especially in
areas of high trypanosome challenge and the occasional use of
prophylactic drugs in curative treatments (Whiteside, 1961; 
Finelle, 1983b).
Cross-resistance in trypanosomes to many of the trypanocides 
used has also been reported (Whiteside, 1961; Na'Isa, 1967 
Williamson, 1982; Williamson et al, 1982; Finelle, 1983a; Lee and 
Maurice, 1983) arising from the close relationships of the drugs' 
chemical composition. Table 8, illustrates the cross-resistance 
existing between trypanocides (Whiteside, 1961). The analysis of 
cross-resistance led to the proposition of the term "sanitive", 
that is, for a drug which cures infections resisting treatment 
with other drugs. For example, isometamidium is effective
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against trypanosomes resistant to quinapyramine, homidium, 
diminazine and pyrithidium. "Sanitive pairs" are thus pairs of 
potent curative drugs which do not provoke resistance the one to 
the other, such as; homidium and diminazine or metamidium and 
diminazine, or isometamidium and diminazine (Whiteside, 1961; 
Toure, 1973b; Anon, 1979; Finelle, 1983a).
The alternate use of two drugs that do not cause mutual 
cross-resistance may therefore furnish a reasonable prospect of 
controlling African animal trypanosomiasis provided the standards 
of veterinary supervision and animal husbandry are high.
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CHAPTER TWO
THE EXTENT OF ISOMETAMIDIUM BINDING TO SERUM PROTEINS 
IN TREATED ANIMALS
72
INTRODUCTION
Following an intramuscular injection, isometamidium chloride 
primarily accumulates at the injection site followed by the 
liver, kidney and spleen from where it is slowly released into 
the circulation. However, when the drug is injected 
intravenously, large amounts tend to accumulate in the 
parenchymatous organs, particularly liver and kidneys (Philips 
et al, 1967; Braide and Eghianruwa, 1980; Kinabo and Bogan, 
1 9 8 8 a ) .
Philips et al (1967) reported that isometamidium is bound by 
serum albumin, deoxy- and ribonucleic acids, heparin and 
hyaluronic acid. The binding to DNA is further supported in the 
studies by Wagner (1971) and Kinabo and Bogan (1987) who 
advocated an existence of two binding sites with different 
affinities for isometamidium. A strong binding seems to be due 
to intercalation, and a weaker binding involves electrostatic 
interaction between the drug and phosphate groups of DNA. 
Insoluble complexes are also formed with nucleic acids and 
mucopolysaccharides when there is neutralisation of the cationic 
drug and the polyanionic molecules. However, further studies 
pertaining to the acclaimed extensive binding of the drug to 
plasma proteins have not been reported.
It has been shown following treatment that isometamidium is 
cleared rapidly from serum to concentrations of 0.7 and 1.7 ^ig/ml 
plasma 24 hours after an intravenous administration of 0.5 and
1.0 mg/kg BW respectively in camels (Ali and Hassan, 1984); 
2.17 pg/ml serum 24 hours after an intramuscular administration
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of 0.5 mg/kg BW in goats (Braide and Eghianruwa, 1980); and below 
10 ng/ml serum within 24-48 hours after either an intravenous or 
intramuscular administration of 0.5 mg/kg BW in cattle (Kinabo 
and Bogan, 1988b). The kinetic analysis of the serum 
concentration versus time data by Kinabo and Bogan (1988b) in 
cattle, revealed a terminal phase elimination half-life of 
1.3 hours and a volume of distribution of 1.2 1/kg.
The major constraint in studying chemoprophylaxis of African 
animal trypanosomiasis, and consequently the possible 
significance of drug resistance has been the lack of suitable 
sensitive tests which are able to detect very low levels of 
isometamidium chloride in serum and ti s s u e s . The main problems 
associated with the assay of isometamidium chloride in biological 
matrices are the low drug concentrations in plasma of treated 
animals, its apparent extensive binding to plasma and tissue 
macromolecules, and its instability in extreme pH conditions and 
high temperatures (Kinabo and Bogan, 1 9 8 8 a ) .
The existing assays for isometamidium chloride in serum and 
tissues include, spectrophotometric assays (Philips e_t al, 1967; 
Braide and Eghianruwa, 1980), HPLC assay of Perschke and Vollner 
(1985), radi oimmunoassay (Kinabo and Bogan, 1988c) and a solid 
phase extraction followed by ion-pair reversed-phase HPLC 
described by Kinabo and Bogan (1988b) .
The spectrophotometric assay is not specific and 
e f f i c i e n t l y  sensitive to determine isometamidium chloride 
concentrations lower than 1 p.g/ml in plasma or 2 p.g per gram of 
tissue. The HPLC assay (Perschke and Vollner, 1985) has a better
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sensitivity with a detection limit of 100 ng/ml serum. However, 
it uses large amounts of sample (about 1 ml of serum) and is 
indirect in that isometamidium is first converted to homidium 
before separation and detection. The radioimmunoassay for 
isometamidium using anti - isometamidium antibodies raised in sheep 
and ^ C - l a b e l l e d  isometamidium as a radioligand has a limit of 
detection of 29 ng/ml serum without extraction although it 
probably has potential for improvement. The limits of detection 
of the ion-pair HPLC method with fluorimetric detection (Kinabo 
and Bogan, 1988b) are 10 ng/ml of serum and about 400 ng/g of wet 
tissue.
Recently, an ultrasensitive ELISA capable of detecting 
isometamidium as low as 5 - 10 pg/ml in sera of treated cattle 
has been developed by Whitelaw et al (in press). The assay 
utilises anti -isometamidium antibody raised in sheep and 
functions on the basis of competition. Isometamidium conjugated 
to egg albumin is adsorbed on to the solid phase, and this 
competes with isometamidium in the test sample for binding sites 
on the anti - isometamidium antibody. At high sample drug 
concentration, the anti -isometamidium antibody complexes 
predominantly with the drug in the liquid phase and to a much 
lesser extent to that on the solid phase, hence low optic density 
(OD) results on the development of the assay with a chromophore. 
Conversely, a high OD is obtained at low sample concentration of 
isometamidium.
The study described in this chapter was aimed at determining 
the extent of binding of isometamidium chloride to serum proteins
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by employing TCA precipitation and ultra-filtration methods for 
the separation of free and bound drug. The levels of the 
isometamidium were measured by the recently developed ultra­
sensitive ELISA.
MATERIALS AND METHODS
Production and Purification of Sheep Anti-Isometamidium Antibody 
(IgG)
Materials
Isometamidium antiserum produced in sheep was kindly donated 
by Elizabeth Gault (Joint ODA Project, Departments of Veterinary 
Physiology and Parasitology, Glasgow Veterinary S c h o o l ) . The 
immunogen used for challenge was isometamidium conjugated to 
porcine thyroglobulin (PTG).
An LKB fraction collector (LKB Instruments Ltd. 6522 A) was 
used to collect the separated fractions of the purified antibody 
and a protein estimation kit was obtained from the Sigma Chemical 
Company.
The chemicals and reagents used were of analytical grade 
purchased from British Drug House.
Methods
A saturated ammonium sulphate solution was prepared by 
heating at 50°C and stirring a mixture of 1000 g (NH^)SO^ in 
1000 ml distilled water until most of the salt was dissolved. 
This was left to stand overnight at room temperature before the 
pH of the solution was adjusted to 7.4 by addition of sulphuric
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acid.
A multi-step method described by Catty and Raykundalia 
(1988) to precipitate the IgG fraction of the immunoglobulin was 
followed albeit, with modifications, as described below.
Saturated ammonium sulphate solution at 0°C was added drop 
wise to 45 ml of whole antiserum on ice with constant stirring 
until a 33% saturated (v/v) final concentration was reached. The 
mixture was then left to stand for one hour on ice with mixing 
(without frothing) before being centrifuged at 3,000 rpm for 15 
minutes. The precipitate was washed in ice-cold 33% (v/v in 
distilled water) ammonium sulphate, by centrifugation and 
resuspension.
The final precipitate was dissolved without frothing in 
0.01M phosphate buffer, pH 7.2 to give about 15 ml of an euglobin 
solution which was then dialysed against the same buffer 
overnight.
A DEAE column was prepared and equilibrated with the same 
phosphate buffer allowing 15 - 20 ml as settled volume per 5 ml 
euglobin solution. The column was well washed and when the 
packing was completed, excess buffer was removed from the top and 
the euglobin layered-on. When the euglobin entered the matrix, 
the top-end of column was attached to a gradient buffer reservoir 
(0.01M - 0.71M phosphate buffer pH 7.2). Using a LKB fraction 
collector, the column was run at about 20 ml/hour and 5 ml 
samples collected.
Three peaks which were collected were then concentrated 
using polyethylene glycol 20,000.
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Sephadex G200 was equilibrated overnight using 0.1M TRIS-HCl 
buffer pH 7.2. It was then washed using the same buffer, 
degassed and transferred to a column. The same buffer was passed 
for one hour to make the column settle before the concentrated 
fractions I, II and III were separately run through using a 
homogeneous TRIS-HCl buffer (0.1M pH 7.2).
The protein contents of the eluted sub-fractions were 
determined by using the reagents of and the method given by Sigma 
Chemical Company (Procedure No. P5656 of 1987) based on
Peterson's modification of the micro-Lowry method.
The purity of the subfractions was determined by
immunoelectrophoresis, using 5 p^il of the eluate per well and a 
donkey anti-sheep IgG antiserum.
Trichloracetic Acid (TCA) Precipitation and Ultrafiltration of 
Serum Samples from Isometamidium-Treated Cattle
Materials
R
Centriflo membrane cones type CF25 with polyethylene 
support cones (CS1A) and polycarbonate collecting tubes (CT1) 
were purchased from Amicon Ltd., Uppermill, Stonehouse, Great 
Britain. The membrane cones are inert, non-cellulosic polymer 
laminated on tough inert substrate and have more than 95%
retention of molecules with molecular weight above 25 k D .
Protein estimation kit reagents (TCA, sodium deoxycholate 
and Lowry's reagent) obtained from Sigma Chemical Company were 
used for TCA precipitation of proteins in the samples.
The samples included a normal bovine serum (NBS) pooled from
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calves (347, 41, 42, 43. 44, 45) at day 0; sera of the same
calves from day 30 after being treated with isometamidium
(Samorin ) at 0.5 mg/kg BW, and bovine serum albumin (30 mg/ml).
Methods
To 1 ml of serum from each calf treated with isometamidium
(CSS), normal bovine serum (NBS) and bovine serum albumin (BSA),
0.1 ml of sodium deoxycholate was added, mixed and left to stand 
at room temperature for ten minutes. 0.1 ml of TCA was then 
added and immediately thoroughly mixed by agitation and left to 
stand for 30 minutes at room temperature.
The tubes were then centrifuged for 15 minutes at 3,000 rpm 
before the supernatants were separated from their respective 
precipitates. The precipitates were then redissolved using 
Lowry's reagent. The supernatants and the redissolved 
precipitates were separately dialysed overnight in 0.1M phosphate 
buffer pH 7.4. All the samples were done in duplicates. The 
concentration of isometamidium chloride in the dialysed samples 
was determined by ELISA.
Centriflo membrane cones were soaked in distilled water for 
about one hour before use. The membrane cones were placed into 
CSlA supports by rotating the support counter clockwise, pushing 
the cone down firmly until its tip protruded through the bottom 
and the cone was fully seated in the support, locking it in 
place. The supports were pushed into the CT1 tubes, seating the 
flanges on the t u b e s , and excess water was removed from the 
membrane cones by centrifuging the sets for a few minutes prior 
to insertion of the samples.
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For ultrafiltration, duplicates of 2 ml each of serum from 
the calves treated with isometamidium (347, 41, 42, 43, 44, 45),
N B S , and BSA were separately put in the membrane cone sets and 
centrifuged at 1000 g for two hours to achieve complete 
ultrafiltration. Isometamidium levels were determined in the 
ultra filtrates by ELISA.
Determination of Isometamidium Levels in Samples by Enzyme Linked 
Immunsorbent Assay (ELISA)
Materials
R
Isometamidium chloride (Samorin ) was obtained from RMB 
Animal Health Limited. The buffer salts were of analytical 
reagent grade from British Drug House. Microtitre plates 
obtained from Alpha Laboratories were used for the ELISA and 
absorbance was measured on a Multiskan MCC at 405 nm. Samples 
were normal bovine serum (NBS) pooled from calves (347, 41, 42,
43, 44, 45) at day 0; sera of the same calves from day 30 after
being treated with isometamidium at 0.5 mg/kg body weight, bovine 
serum albumin and their respective ultrafiltrates and dialysed 
TCA redissolved precipitates and supernatants. Other control 
samples included, 1 ml distilled water ( ^ 0 )  ; 1 ml ^ 0  and 0.1 ml 
sodium deoxycholate (DOC); 1 ml H^O, 0.1 ml DOC and 0.1 ml TCA; 
1 ml H2O, 0.1 ml DOC, 0.1 ml TCA and 1 ml Lowry's reagent. The 
DOC, TCA and Lowry's reagent were purchased from Sigma Chemical 
Company contained in a protein estimation kit. Other reagents, 
unless specified, were purchased from Sigma Chemical Company.
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Methods
The raicrotitre wells were coated by passive adsorption with 
egg albumin-isometamidium conjugate (0.0125 ratio) diluted 
1 : 1000 with 100 mM carbonate/bicarbonate buffer pH 9.0. The 
plates were washed with distilled water following an overnight 
incubation at 4°C, dried at 37°C then stored desiccated at 4°C 
until they were used. Prior to assay the plates were washed four 
times with (PBST) phosphate buffered saline-Tween (1000 ml 0.15M 
phosphate buffered saline pH 7.2, 500 ul Tween-20).
Two sets of isometamidium standards ranging from 500 ng/ml 
to 50 fg/ml were prepared by diluting isometamidium in 0. 1M 
phosphate buffer pH 7.4 and normal bovine serum.
5 i^l of the isometamidium standards or test samples were 
added to the wells followed immediately by 100 p.1 of the purified 
sheep anti-isometamidium antibody diluted 1 : 5000 with PBST. 
The assay was performed in triplicate for the standards and 
duplicate for the test samples.
The plate was incubated overnight at 4 ° C , the wells emptied 
and washed three times with PBST. 100 jj.1 of alkaline phosphatase 
labelled donkey anti-sheep IgG diluted at 1 : 1000 in PBST was 
then added to the microtitre w e l l s , and the plates incubated for 
one hour at 4°C.
After washing the plate three times with PBST, 100 ul of 
substrate, that is, 2 mg/ml p-nitrophenyl phosphate disodium in 
substrate buffer (97 ml diethanolamine, 101 mg M g C ^ ,  800 ml
distilled water) was added to each well.
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The plate was read in a Multiskan MCC at 405 ran after 15 - 
30 minutes incubation at room temperature. Standard curves using 
the standard isometamidium dilutions were drawn and used for 
determining the isometamidium concentrations of the s a m p l e s .
RESULTS AND DISCUSSION
The euglobin obtained by ammonium sulphate precipitation 
yielded three peaks, namely M G I , II and III (Figure 6) following 
a molecular weight gradient separation with 0.01M - 0.71M 
phosphate buffer pH 7.2 through a DEAE column. The three peaks 
were concentrated to 12 ml for MGI and 5 ml for MGII and MGIII. 
When these three peaks were further purified by passing through a 
Sephadex G200 column each yielded two subfractions, that is,
19.5 ml and 18.0 ml for MGI fraction I and II respectively;
9.0 ml and 10.5 ml for MGII fraction I and II respectively; and
4.5 and 13.0 ml for MGIII fraction I and II respectively, as 
shown in Figures 7 - 9 .
By employing immunoelectrophoresis, the purity of MGII 
fraction II proved to be the best (Figure 10) and it was the one
that was used for various analyses of isometamidium chloride.
It will be noted from the isometamidium standard curves 
drawn (Figure 11) that the optic densities of the standards in
normal bovine serum were lower than those in phosphate buffer at
the same concentrations. This can be due to the effect of the 
serum proteins in the assay, probably brought about by the 
binding of the drug to the serum proteins. However, in both 
curves, the assay shows to be most sensitive between 500 fg and 
500 pg. The two standard curves were important when determining
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Figure 11
Isometamidium Standard Curves in Phosphate Buffer (PB) 
and Normal Bovine Serum (NBS).
the sample isometamidium concentration so as to take into effect 
the medium in which isometamidium was contained.
Table 9 shows the isometamidium concentrations in the 
samples analysed. It seems that TCA affects the assay of 
isometamidium by lowering the optical density, hence giving false 
high isometamidium results as depicted by comparing the results 
obtained with the redissolved TCA precipitates of CSS, NBS, BSA 
and the control samples containing TCA. Lowry's reagent also 
seems to have a similar effect as TCA. To this effect, the 
results obtained by TCA precipitation were disregarded and not 
considered in making any conclusions.
Analysis of the ultrafiltrates from the (CSS) isometamidium 
containing sera (347, 41, 42, 43, 44, 45) by ELISA showed that
about 99% of the isometamidium remained in the protein matrix. 
However, the precentage recovery of isometamidium in the 
ultrafiltrates of the control isometamidium solutions in
distilled water were 95% and 98%, indicating that some of the
drug may have been retained or bound to the ultrafilter membrane. 
Thus, from the results it can be concluded that 95-99% of 
isometamidium chloride was bound to serum proteins in
isometamidium treated animals.
The studies on the binding of various drugs to bovine serum 
albumin (Birkett and Wanwimolruk, 1985), human c<^ —  acid 
glycoprotein (Muller et al, 1985), lipoproteins (Urien, 1985), 
gammaglobulins (Albengres, 1985), leucocytes and platelets
(Lemaire, 1985) and erythrocytes (Ehrnebo, 1985) have indicated 
that serum proteins have the priority and higher capacity to bind
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Table 9
Sample Concentrations of Isometamidium Chloride as Determined by ELISA
Description of Contents
Mean
O.D.
Samorin % Recovery or 
Concentration Unbound
per ml Isometamidium
Serum with Isometamidium
css*1
0.97 5 Pg
TCA Supernate of CSS*^ 1.352 1.7 pg 34.0
Redissolved TCA precipitate of CSS J 1.329 2.75 pg
Normal bovine serum (NBS) 1. 379 < 50 fg
TCA supernate of NBS 1.434 < 50 fg
Redissolved TCA precipitate of NBS 1.297 4 pg
Bovine serum albumin (BSA) 1. 391 < 50 fg
TCA supernate of BSA 1. 393 < 50 fg
Rcdissolved TCA precipitate of BSA 
Control samples:
1.326 2.75 pg
(a) 1.0 ml H~0 + 0.1 ml sodium 
deoxycholate
1.408 < 50 fg
(b) As (a) + 0.1 ml TCA 1. 340 2 Pg
(c) As (b) + 1.0 ml Lowry's reagent 1.289 4. 25 pg
(d) Distilled water 1.497 < 50 fg
Ultrafiltrate of CSS 1.369 < 50 fg 0.01
Ultrafiltrate of NBS 1.408 < 50 fg
Ultrafiltrate of 500 pg 
isometamidium in water
0.745 475 pg 95.0
Ultrafiltrate of BSA 1.427 < 50 fg
Ultrafiltrate of CSS 1.370 < 50 fg 0.01
Ultrafiltrate of 2.5 ug/ml 
isometamidium solution in water
0.198 2.45 jjg 98 .0
*Mean values for calves 347,41, 4-2, 43,44,and45 with a ranae
of 4.9-5.lbpq CM); 1.6-1.9pq ( * 2 ) ; and 2.5-3.Opa f*3).
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drugs than the cells found in blood. Thus, evaluation of the 
binding of isometamidium to serum proteins is of importance when 
considering its pharmacokinetics in treated animals. It is 
probable that this extensive binding of isometamidium chloride to 
serum proteins has contributed to the problems faced in the 
development of analytical methods for its detection in sera of 
treated a n i m a l s .
The extensive binding of isometamidium to serum proteins has 
important implications in the mechanism of uptake of the drug by 
trypanosomes in vivo in treated a n i m a l s , which is currently
unknown. The trypanosome cell coat is composed of a single
glycoprotein molecule of about 65 kDa (Vickerman and Barry, 1982; 
Pays, 1986; Barbet et al, 1989) and it is possible that this 
surface coat covering the trypanosome plasma membrane is capable 
of binding the drug.
Reports of studies of different drugs binding to albumin 
(Birkett and Wanwimolruk, 1985) and human o ^ - a c i d  glycoprotein 
(Muller et al, 1985) indicates that drugs are bound to 
hydrophobic areas on these molecules. Isometamidium chloride 
exhibits some hydrophobic properties due to the phenyl moieties 
present in the molecule (Kursch et al, 1983; Kinabo and Bogan, 
1988a). It is possible that the trypanosome surface coat has
hydrophobic areas which are capable of binding the drug and
eventual absorption into the cell which may be rapid as evidenced 
by its rapid clearance from serum and accumulation into 
parenchymatous organs in treated a n i m a l s .
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It is interesting to note that the prophylactic effect of
isometamidium is due to the characteristic retention of the drug
at the injection site and the accumulation in parenchymatous
organs to be released slowly into the circulation. It is
apparent that the amount of the drug released into the
circulation is very small and for this to have an effect on the
the
trypanosome, it is suggested that^trypanosome surface coat must 
have sites with higher affinity to bind isometamidium than the 
plasma proteins.
Comparative studies of isometamidium binding to the 
trypanosome surface coat in isometamidium-sensitive and resistant 
strains might also be of great value. It is possible that there 
is mutation or genetic change which could result in the reduction 
of hydrophobic binding sites or the affinity of the trypanosome 
surface coat to isometamidium in drug resistant trypanosomes.
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CHAPTER THREE
THE DEVELOPMENT OF A CHEMILUMINESCENT WESTERN-BLOT TECHNIQUE FOR 
THE DETECTION OF PROTEINS BINDING ISOMETAMIDIUM 
IN THE SERUM OF TREATED ANIMALS
87
INTRODUCTION
The phenomenon of chemiluminescence and bioluminescence has 
been known for a long time, however it is only in the 1980s that 
its applicability has been introduced into clinical laboratories.
Chemiluminescence is the phenomenon observed when the 
vibronically excited product of an exoergic chemical reaction 
reverts to its ground state with the emission of photons (Shaw,
1985) . The photophysical process involved is illustrated by 
the Jablonski diagram (Figure 12) which also serves to 
differentiate chemiluminescence from fluorescence and 
phosphorescence.
The types of chemical reaction involved in chemiluminescence 
are usually oxidation reactions and one of the best known 
examples is the reaction of luminol (5-amino-2, 3-
dihydrophtalazine-1, 4-dione) with peroxide or perborate (Kricka 
and Thorpe, 1984; Shaw, 1986). In this reaction (Figure 13) the 
product, aminophthalate is produced in an excited state and it 
decays to the ground state with the emission of light (A 
max 425 n m ) .
In chemiluminescent reactions mediated by luminol, only 1% 
of the reacting molecules produce light emission, as such they 
are less efficient as compared to natural bioluminescent 
reactions (Kricka and Thorpe, 1984). Bioluminescent reactions 
are also oxidation reactions involving catalytic enzymes 
(luciferases) and their substrates (luciferins) which are 
responsible for the light emitted by the firefly and marine 
bacteria such as Vibrio fischerii.
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Figure 12
Jablonski Diagram. It illustrates that fluorescence and phosphoresence 
processes require excited state population by irradiation of ground state 
molecules; whereas, chemiluminescence involves the formation of the products 
of a chemical reaction in excited state. Light emission occurs with for­
mation of ground state molecules.

Acridinium esters reaction also proceeds in the presence of 
dilute alkaline hydrogen peroxide, however, unlike luminol it 
does not require a catalyst. Thus, levels of background 
chemiluminescence and interference which are characteristically 
high in complex oxidation systems are very low (Shaw, 1985;
1986).
In analytical luminescence, a sample and a luminescent 
reagent are mixed together and placed in front of a light 
detector, either a silicon photodiode or a photomultiplier tube. 
The total amount of light or the peak light intensity is related 
to the concentration of the analyte in the sample (Kricka and 
Thorpe, 1984).
Luminescence analyses have been employed in the measurement 
of cellular ATP using firefly luciferase-luciferin reaction in a 
p r e -transfusion viability of red blood cells and platelets, ATP 
levels in bacteriuria, and red cell ATP levels in studies of 
various disease states such as diabetes, uraemia and hexokinase 
deficiency. In immunology, chemiluminescence has been used to 
study the phagocyte function in conditions such as chronic 
glanulomateous disease, burns, renal disease and myeloperoxidase 
deficiency. Luminescent reaction has also been used to serve as 
an indicator reaction for peroxidase, ATP or NADH produced in an 
initial reaction in the assays for glucose, creatine kinase and 
alcohol (Kricka and Thorpe, 1984). Chemiluminescent immunoassay 
has also shown to be a logical and viable alternative to systems 
using radioisotopes. It is a "non-radiometric", sensitive and
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rapid immunoassay for a wide range of analytes including alpha- 
fetoprotin, ferritin, choriogonadotropin, prolactin, thyrotrophin 
and thyroxine (Shaw, 1985).
Scheneppenheim and Rautenberg (1988) adapted a luminescence 
assay for the detection of peroxidase-labelled secondary 
antibodies which react specifically with antibodies to human 
immunodeficiency virus (HIV) on Western-blots. They demonstrated 
that the method was one hundred times more sensitive than either 
commercial ELISA or the chromogenic peroxidase assay on the 
blots, and detects seroconversion earlier than any other 
t e c h n i q u e .
Western-blotting, that is, the transfer and immobilisation 
of proteins fractionated on the basis of molecular weight in 
sodium dodecyl sulphate polyacrylanide gel electrophoresis (SDS- 
PAGE) on to membranes has proved to be a useful technique for the 
detection and characterisation of a wide range of proteins 
(Burnette, 1981; La Rochelle and Froehner, 1986; Andrews, 1987; 
Catty and Raykundalia, 1988). Polyacrylamide gels are formed by 
co-polymerisation of acrylamide and bis-acrylamide (N, N'-
methylene-bis-acrylamide). The reaction is a vinyl addition 
polymerisation initiated by a free radical generating system of 
the incorporated ammonium persulphate and TEMED (tetramethyl- 
ethylenediamine). The resulting polymer chains are randomly 
cross-linked by bis creating closed loops and a complex "web" 
polymer with a characteristic porosity which depends on the 
polymerisation conditions and monomer concentrations (Hames, 
1985) .
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SDS-PAGE is able to separate the individual components of a
sample not only on the basis of molecular size but also molecular
shape. The technique therefore, permits determination of the
molecular weights of proteins having different molecular shapes
by splitting the proteins' s-s covalent bonds into their
a n d  a thiol
individual polypeptide chains by denaturation with SDSy^ These 
chains are negatively charged in proportion to their length such 
that their electrophoretic mobility (Rf) depends on their 
molecular weight alone. With SDS-PAGE therefore, the molecular 
weight of a sample protein(s) can be determined by comparing the 
electrophoretic mobilities with those of known protein markers 
(Laemli, 1970; Sigma, 1982; Ham e s , 1985; Andrews, 1987).
Several different types of immobilising matrix are employed 
in Western-blotting, however, nitrocellulose (NC) is widely used. 
The mechanism of protein binding to NC is complex and it is still 
not fully understood; but hydrophobic interactions are probably 
important since the addition of non-ionic detergents such as 
Triton X-100 aids subsequent elution of protein from the matrix 
(Andrews, 1987). The incorporation of methanol tends to 
stabilise the geometry of the gel during transfer and also 
increases the binding capacity of transfer membranes for protein, 
but reduces the efficiency of protein elution from the gel 
particularly SDS-PAGE gels. Thus, long electroelution (more than 
12 hours) times may be required for efficient transfer of large 
proteins. For Western blotting, Immobilon-P (teflon) transfer 
membrane, a strong hydrophobic polyvinyl difluoride (PVDF) has
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been shown by the manufacturer (Millipore, 1987) to be superior 
to nitrocellulose and nylon.
About 5 ng of transferred and immobilised proteins in blots 
can be detected with biotin-avidin technology, the sensitivity 
and efficiency being comparable to that of silverstaining in 
polyacrylamide gels (La Rochelle and Froehner, 1986; Pierce, 
1989) . The biotin molecule can easily be activated and coupled 
to either antigens or antibodies, usually with a complete 
retention of activity. N-hydroxysuccimide (NHS) esters react 
with primary amines to form amide bonds. The reaction occurs via 
nucleophilic attack by an unprotonated amine (generally lysine 
epsilon groups) towards NHS ester, resulting in a stable amide 
bond formation and release of N-hydroxysuccimide (Figure 14) . 
The reaction is favoured in alkaline pH which keeps primary 
amines in an unprotonated state; also the hydrolysis of the NHS 
ester is favoured in dilute protein solutions.
Streptavidin (MW 60,000) is more commonly used than avidin. 
Unlike its glycoprotein counterpart, streptavidin does not 
contain carbohydrate moieties thus, it has a lower isoelectric 
point (pi = 5) resulting in reduced non-specific binding (Hoffman 
et al, 1980; Haeptle et al, 1983). Streptavidin
is isolated from Streptomyces avidini and purified over an 
affinity column to assure the integrity of the four biotin- 
binding sites (Pierce, 1989). An enzyme-streptavidin conjugate 
is able to bind any immobilised biotinylated antibody or antigen 
in an assay, and the resulting colour, fluorescence or 
luminiscence after the addition of an appropriate substrate can
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be correlated to the concentration of the antibody or antigen 
p r e s e n t .
The work detailed in this chapter was aimed at identifying 
serum proteins to which isometamidium chloride binds and 
characterise the molecular weight of these proteins in the sera 
of isometamidium-treated animals. To achieve these objectives, 
the principles of SDS-PAGE, Western-blotting, avidin-biotin 
system and chemiluminescence were employed with modifications 
where necessary. For example, X-ray plates were used to detect 
light emitted during the chemiluminescent reaction and therefore 
determine the molecular weight of the isometamiium binding 
proteins and their distribution in the SDS-PAGE gels.
MATERIALS AND METHODS
Production and Purification of Sheep Anti-Isometamidium 
Antibody (IgG)
The sheep anti-isometamidium antibody was raised and 
purified as described in Chapter Two.
Biotinylation of the Purified Sheep Anti-Isometamidium (IgG)
Chemicals and Reagents
N-hydroxysuccinimide ester (NHS-biotin) and dimethyl
sulfoxide (DMSO) were purchased from Sigma Chemical Company; the 
other chemicals and reagents were of analytical grade obtained 
from British Drug House.
Methods
The purified anti -isometamidium antibody was dialysed
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against 0.1M NaHCO^ pH 8.2 - 8.6 for 16 hours and the protein 
content was adjusted to 1.0 mg/ml using distilled water.
N-hydroxysuccinimide ester (NHS-biotin) was dissolved in 
dimethyl sulphoxide to give a concentration of 1 mg/ml. It was 
immediately added to the antibody at a rate of 120 jj.1 per 1 ml of 
the protein, mixed and left to stand for four hours at room 
temperature.
This mixture was dialysed against phosphate buffered saline 
with azide, pH 7.0 - 7.4 for 16 hours, after which the buffer was 
changed and dialysed further with stirring for 15 minutes at room 
temperature.
SDS-PAGE and Western-Blotting of Protein Samples 
Materials
A Bio-Rad power pack and accessories were used. Immobilin-P 
(PVDF teflon transfer membrane) was purchased from Millipore; 
molecular weight protein standards and a silver staining kit for 
proteins from Sigma Chemical Company.
All other chemicals and reagents were of analytical quality 
from British Drug House.
Samples included:-
(a) Sera from animals treated with isometamidium at 
0.5 rag/kg BW i n :-
(i) Cattle Nos. 42, 43, 44, 347, 348 : 2, 16 and 30
days post treatment;
(ii) Goats Nos. 123, 129, 145, 149 : 2, 16 and 30 days
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post treatment;
(iii) Pooled sera from eight mice, four days post 
treatment.
(b) Sera from the same animals prior to isometamidium
treatment;
(c) PTG (porcine thyroglobulin) and EA (egg albumin)
solutions, 4 mg/ml;
(d) PTG-isometamidium and EA-isometamidium conjugates of 
4 mg/ml protein and protein-isometamidium ratio of 
0.005 and 0.0125 respectively;
(e) Isometamidium spiked normal bovine serum (500 j±g / m l ) .
Methods
The samples were diluted using a loading buffer (5 g S D S ,
5 ml 1M TRIS pH 7.5, 2 ml 100 mM EDTA, 10 ml glycerol, 2 ml 0.2%
bromophenol blue all made to a final volume of 95 ml with 
distilled water pH 6.8) to give dilutions of 1 : 4 for cattle, 
goats and mouse samples; 1 : 80 for EA and 1 : 160 for PTG 
samples . They were then boiled in a water bath for five minutes 
to denature the proteins.
Ten percent homogenous polyacrylamide slab gels were 
prepared by mixing 1.25 ml of solution 'A' (3M TRIS-HC1, 0.8% 
SDS, 0.46% T E M E D ) , 2.5 ml of solution 'N' (40% acrylamide, 0.54% 
bis - acrylamide) , 6.2 ml of distilled water; the mixture was then
degassed before 700 jil of 10% ammonium persulphate was added, and 
the mixture poured on to vertical gel casters immediately. 
Propan-l-ol was poured on the setting gel to avoid drying and 
following gel polymerisation (5 - 10 minutes) , was removed and
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the gel top rinsed with distilled water.
A 5% stacking gel prepared by mixing 1.25 ml of solution 
'N', 1.25 ml of solution 'S' (1M TRIS-HC1, 0.8% SDS, 0.4% TEMED)
and 7.5 ml distilled water, degassed and 100 ^ul of 10% ammonium 
persulphate added, was poured on the main gel and gel combs 
inserted to form the wells. The gel was left for 5 - 1 0  minutes 
to set. The function of the stacking gel is to separate the 
samples and concentrate them on to the running gel.
Cast gels were placed in an electrophoresis tank containing 
PAGE running buffer (15 g TRIS base, 72 g glycine, 2.5 g SDS in 
1 litre distilled w a t e r ) . Ten microlitre samples were applied on 
the formed wells, and electrophoresis carried out at 200V for 
about one hour and terminated when the bromophenol blue dye front 
neared the end of the gel.
A  set of protein standards were run alongside the samples 
routinely to calibrate the gels and hence determine the molecular 
weights of the unknown sample proteins. Gels were silver stained 
as per instruction kit (Sigma Tech. Bulletin No. P3040[2-87]. A 
standard curve of ^°S^o (known molecular weights) against 
relative mobilities (Rf) was plotted and used to determine the 
molecular weights of the unknown sample proteins.
After running the samples in SDS-PAGE, the gels were removed 
from the cassettes (casters) by careful detachment from the glass 
plates, and equilibrated in a transfer buffer (9.1 g TRIS, 43.2 g 
glycine in 2.4 litres distilled water, and 600 ml methanol) for 
about 15 minutes to remove electrophoresis buffer salts and 
detergents, and to allow the gel to shrink to its final size.
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Immobilon-P (teflon membrane) was cut at a slightly larger size 
than the gel, soaked in methanol for 2 - 3  minutes, then 
transferred to the transfer buffer for about 15 minutes. The gel 
was overlaid on to the teflon membrane then both were sandwiched 
between buffer soaked double thickness Whatmann No. 1 filter 
papers and fibre pads assembled in a gel holder transfer cassette 
(Figure 15) . Care was taken to remove all air bubbles during the 
assembly. The cassette holder was placed in the blotting tank 
with the teflon paper on the side of the positive electrode. The 
tank was filled with transfer buffer and a transfer effected by 
running for 16 hours at 30V and 0.1A.
After the transfer, the teflon membrane was removed and 
placed in a small plastic tray containing "wash buffer" (5.35 g 
Na2HP04 , 1.95 g N a H 2P04 .2H20 , 42.5 g Nacl, 2.5 ml Tween-20 all in 
five litres of distilled water) to remove any adherent gel which 
may still be attached to the teflon membrane by continuous 
shaking for 15 minutes. The blotted membrane was then stored in 
wash buffer containing 5% marvel at 4°C for up to 16 hours; or 
chemiluminescent assay carried out forthwith. Marvel is a 
protein carrier acting as a blocker to prevent non-specific 
binding during the chemiluminescent assay.
Chemiluminescent Assay for Isometamidium on the Blotted Membrane 
Materials
Biotinylated sheep anti -isometamidium IgG (as described 
previously). X-ray plates were obtained from Du Pont de Nemours 
(Deutschland) GMBH. Streptavidin peroxidase, luminol (5-amino-2,
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C a t h o d e  ( A n o d e  (+ve)
Figure 15
Diagrammatic Presentation of an Assembly of a Gel Holder Cassette 
During an Electrophoretic Transfer. Porous Cassette Holder (1), 
Fibre Pads (2), Filter Papers (3), Gel (4) and PVDF Teflon 
Membrane (5)
3 dihydro -1, 4-phythalazinedione) and dinethylsulfoxide (DMSO) 
were purchased from Sigma Chemical Company, and 4 - iodophonenol 
from Aldrich Chemical Company. All other chemicals were of 
analytical grade from British Drug House.
Methods
The blotted membrane was further washed with continuous 
agitation in a diluting buffer (5.35 g Na^HPO^, 1.95 g 
N a H ^ P O ^ . 2 ^ 0 ,  42.5 g Nacl, 25.0 g Marvel, 2.5 ml Tween-20 all in
five litres of distilled water) for 45 minutes to block n o n ­
specific binding.
Biotinylated sheep anti-isometamidium IgG was diluted at a 
ratio of 1 : 30 in diluting buffer and the blotted membrane 
incubated in this solution with shaking for one hour followed by 
three washes each for three minutes with wash buffer (5.35 g 
N a 2HP04 , 1.95 g NaH2P04 . 2H20 , 42 . 5 g Nacl, 2 . 5 ml Tween-20 all in 
five litres of distilled w a t e r ) .
The blotted membrane was then incubated for 45 minutes in 
streptavidin peroxidase (1 : 400 in diluting buffer) and followed 
by 3 x 3 washes in wash buffer.
A chemiluminescent substrate (iodophenol-luminol solution) 
was prepared by dissolving 40 mg luminol in 5 ml of 1M TRIS base 
then mixed with 2.5 ml 1M TRIS HC1 to obtain a solution with a pH 
of 6.5, and made up to 100 ml using 150 mM NaCl solution. Ten 
milligrams of 4 - iodophenol was dissolved in 1 ml DMSO, added to 
the luminol solution and thoroughly mixed. Immediately before 
use, 32 jxl of 30% H 2<02 solution was added to the iodophenol-
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Blocking the blotted membrane 
w ith d ilu t ing buffer
Rin se w ith wash buffer
Biotinylated sheep anti-isometamidium 
IgG added to pick up the bound 
isometamidium chloride
Rinse w ith  wash buffer
Add it ion  o f  streptavidin-peroxidase 
which w i l l  attach to tlie four 
biotin binding sites
Rinse w ith  wash buffer
Addit ion o f  chemiluminescent 
substrate. Lum ino l is oxidised 
by peroxidase enzyme to emit light 
photons
Lxposure o f  assayed blotted 
membrane to X-ray f i lm  to 
pick up the emitted light
Development o f  exposed X-ray 
plate
Figure 16
The General Steps Followed During a Chemiluminscent Assay
luminol solution.
The blotted membrane was immersed in the fresh substrate and 
removed after one minute, excess solution being shaken off, and
placed in a polythene snap-bag taking care to exclude all air
b u b b l e s .
The snap-bag (containing the blotted membrane) was exposed 
to X-ray plates in a dark room for periods of 10 - 30 seconds, 
and the plates developed.
The relative mobility (Rf) of each band on the X-ray plate 
was calculated by dividing the distance that the band had 
migrated from the point of application by the distance the dye-
front had migrated from the point of application.
RESULTS AND DISCUSSION
The relative mobilities (Rf) of the molecular weight protein 
standards (Figure 17) were used to draw the standard curve 
(Figure 18).
Isometamidium was detected in isometamidium conjugated 
porcine thyroglobulin (PTG) and egg albumin (EA) by 
chemiluminescence as evidenced by the bands observed in the 
developed X-ray plates (Figure 19). No bands were observed in 
the control runs of neat PTG and EA. The PTG-isometamidium 
conjugate remained mainly at the point of application and this is 
due to the high molecular weight of PTG (600 k D ) . The big smear 
observed may either be diffusion of the protein from the 
application point, breakdown complexes of the PTG-isometamidium 
during its denaturing with SDS, excess application or diffusion 
of photons. This may also be the case for the diffuse band
Figure 17
Silver stained protein standards in a 10% homogeneous 
SDS-PAGE gel. Bovine serum albumin (A), Plasminogen (B), 
Fibrinogen (C), Myosin (D), Mixed standards (E), Haemoglobin (F), 
Phosphorylase (G), p-galactosidase (H) and Egg albumin (I).
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Figure 18
A Standard Curve using M olecular Weight Protein Standards 
in a 10% Homogeneous SDS-PAGE gel.
(a) (b) (c) (d)
Figure 19
Chemiluminescent Western-blot for Isometamidium, 
Isometamidium-conjugated porcine thyroglobulin (a), 
Isometamidium conjugated Egg albumin (b), Porcine 
thyroglobulin (c ), Egg albumin (d).
observed with EA-isometamidium.
Likewise, the drug was also detected by chemiluminescence in 
sera of isometamidium treated cattle, goats and mice, whereas no 
bands were observed in the control sera of the same species 
(Figure 20).
In sera of isometamidium treated cattle, one strong band 
with two weaker bands were observed (Figures 20 and 21) in the 
blots of denatured non-reduced PAGE gels. Even at times when all 
the bands were weak, at least one seemed to be stronger 
(Figure 21) . Since the strength of the bands is determined by 
the amount of photons emitted by oxidised luminol, which is in 
turn influenced by the levels of streptavidin peroxidase-antibody 
(anti-isometamidium IgG) and antibody-isometamidium interactions; 
then sera with low amounts of the drug will show weaker bands. 
The stronger band in cattle sera correlate to the band obtained 
with isometamidium spiked albumin and isometamidium spiked normal 
bovine serum (Figure 22) with a relative mobility (Rf) of 0.41 
which corresponds to molecular weights of about 140 k D . The 
weaker bands have Rfs of 0.36 and 0.46 which correspond to about 
155 and 122 kD respectively.
In sera of isometamidium treated goats and mice, only one 
band was observed with a relative mobility (Rf) of 0.09 which 
corresponds to a molecular weight of about 300 kD.
Philips et al (1967) reported the binding of isometamidium 
to albumin, DNA, RNA, heparin and hyaluronic acid and further 
presumed albumin to be the major binding component in rat serum. 
The chemiluminescent results in this study are suggestive that
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Cattle Goat Mouse 
(a) (b) (a) (b) (a) (b)
Figure 20
Chemiluminescent Western-blot for Isometamidium 
in serum from treated animals (a) and untreated 
animals (b) Serum of calf No.347> 16 days post
treatment is shown for cattle.
Chemiluminescent Western-blot for Isometamidium 
in bovine from treated animals (a) and untreated 
animals (b)
A B C
Figure 22
Chemiluminescent Western-blot for Isometamidium in 
isometamidium-spiked normal bovine serum (A), normal 
bovine serum (B), isometamidium spiked bovine serum 
albumin (C ).
the main protein that does bind the drug in sera of treated 
cattle has a molecular weight of about 140 kD and it is probably 
a dimer of bovine serum albumin. In mouse and goats, the protein 
with about 300 kD which binds isometamidium cannot be identified 
with certainty as an albumin quadruplet or a pentamer. 
Preabsorption of isometamidium treated sera with monoclonal 
antibodies against albumin will be an aid in ascertaining if 
albumin is the major protein that binds isometamidium chloride.
Other workers have identified six binding sites for various 
drugs on the albumin molecule. However Birket and Wanwimolruk 
(1985) have suggested there may be additional binding sites for 
drugs and endogenous compounds. The albumin binding sites are 
hydrophobic areas with a positive charge located at the entrance 
to the binding site. The hydrophobic properties of isometamidium 
chloride (Kinabo and Bogan, 1988a) may explain the binding of 
this drug to albumin. A feature of all albumins is the presence 
of adjacent cysteine-cysteine residues which are the basis of a 
repeating loop structure formed by disulphide bridges. These 
loops stabilised by disulphide bonds make this molecule stable in 
acids, bases and denaturing solutions. Proteolytic fragments of 
bovine serum albumin also retain helical structure, some binding 
sites and antigenic sites (Birket and Wanwimolruk, 1985).
Studies employing equilibrium dialysis and circular 
dichroism in other drugs by Muller et al (1985) confirmed that 
human c ^ ^ - a c i d  glycoprotein (o<^-AGP) has only one common 
binding site for most drugs. The site is a remote high affinity 
hydrophobic area within the protein component of the glycoprotein
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molecule. Also, the basic character of the drugs does not appear 
to be obligatory for high-affinity binding to the site, and that 
hydrophobic interactions are more important than electrostatic 
interactions. In this study, no bands were observed by 
chemiluminescence in the sera of isometamidium treated animals 
corresponding to c<^-AGP (molecular weight 41.1 kD) , thus either 
very little or no isometamidium is bound to this protein. It is 
also important to note from the studies by Birket and 
Wanwimoluruk (1985) and Muller e_t al (1985) that albumin has a 
higher capacity to bind drugs than O^^-AGP. It is possible that 
the other isometamidium binding proteins of about 122 and 155 kD 
could be glycoproteins.
Other blood components that bind drugs include erythrocytes 
(Ehrnebo, 1985), leucocytes and platelets (Lemaire, 1985), plasma 
lipoproteins (Urien, 1985) and immunoglobulins (Albengres, 1985). 
The major binding components in erythrocytes are haemoglobin, 
carbonic anhydrase and the cell membrane. In circulating blood, 
there is a competition between plasma proteins and blood cells 
for the free drug available. High plasma binding may result in 
low distribution to erythrocytes in spite of high affinity of the 
drug to red blood cells. Generally, the binding of a drug to 
erythrocytes is only important for the total body distribution if 
the binding is extremely strong or if the drug has a low 
distribution volume (Ehrnebo, 1985).
Ehrnebo (1985) suggested that erythrocytes would exhibit the 
lowest priority pharmacokinetically to bind drugs compared to 
albumin and o<.^-AGP. There is no evidence of isometamidium
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erythrocytes
binding to ^  , but an investigation of isometamidium-
erythrocyte interaction is worthwhile when studying its complete 
pharmacokinetic analysis bearing in mind that erythrocytes form 
their own compartment in the circulating blood. Also, the major 
protein of the erythrocytes, haemoglobin, amounts to 7 - 8 times 
as large as the amount of albumin in the whole blood.
Drug-lipoprotein complexes may function as vehicles for drug 
absorption or for drug delivery to specific tissues particularly 
parenchymal cells via the lipoprotein receptor-mediated pathway 
and play a role in degradation of drugs in plasma. Nearly all 
types of drugs are capable of binding to isolated lipoproteins 
provided they exhibit a certain degree of hydrophobicity (Urien,
1985) . It is possible that isometamidium is bound to
lipoproteins; if so, it may form a basis in explaining its rapid
clearance from serum following parenteral administration and its 
accumulation in specific tissues especially the parenchymatous 
organs. Another mechanism, receptor independent is responsible 
for removal of lipoproteins from plasma by the scavenger cells of 
the reticulo-endothelial system (Urien, 1985). The removal of 
the drug from plasma and its subsequent accumulation in the 
liver, kidneys and spleen is also suggestive of isometamidium 
binding to lipoproteins.
In humans, the high density lipoproteins (HDL) , o ^ -
lipoproteins have molecular weights ranging from 148 - 154kD for 
VHDL; 166 - 175 kD for HDL; 195 kD for HDL^ and 435 kD for HD L 2 ;
whereas low density lipoproteins (VLDL and LDL) , the ^ 2’
lipoproteins have higher molecular weights ranging from
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3.2 x 10 - 20 x 10 kD. It is possible that what is retained at
the point of application as seen on the developed X-ray plates of 
sera of isometamidium treated animals, could be lipoproteins of 
higher molecular weights. Also, it is possible for the 
characterised isometamidium binding proteins of about 122 and 
155 kD to be lipoproteins (HDL). The existence of an endogenous 
carrier-mediated mechanism or an active transport system for
isometamidium chloride in vivo has been hypothesised by Kinabo 
( 1 9 8 8 a ) . It is possible that lipoproteins play the role of 
endogenous carriers and if it is s o , they may also aid in the 
uptake of the drug by the trypanosomes. It is therefore
important in future work to ascertain whether isometamidium binds 
to serum lipoproteins.
Leucocytes and platelets also have a high affinity but low 
capacity to bind drugs. The high affinity is due to an
interaction with pharmacological factors located on the cell
m e m b r a n e s . These cells are capable of accumulating drugs by
specific transport or binding systems, and have necessary enzymes 
for metabolising drugs (Lemaire, 1985). Some degree of binding 
of isometamidium chloride to leucocytes has been observed (I. 
Sutherland, personal communication) thus, further studies in this 
area may help to explain in part the metabolism of the drug
in v i v o .
Gammaglobulins (V- G )  are large polypeptide molecules which 
b i n d  to drugs much less than albumin. Drugs bind to the ends of
the two arms of ^  -G, the site located at a crevice between
(variable region of light chain) and (variable region of heavy-
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chain) fragments, the shape and size of the binding site varying
mainly due to the exchange, deletion or addition of amino acids
in the hypervariable regions. The drug binding functions of 
immunoglobulins are drug recognition of foreign matter and drug 
binding to cell receptors. Generally, the amount of the drug
which binds to H  -G is less than 1% of the total blood binding 
when related to physiological concentrations of blood proteins, 
thus, immunoglobulins play no relevant role in drug transport or 
in the drug interaction and have no effective function in
carrying therapeutic amounts of drug towards a specific target 
(Albengres, 1985). However, considering that hypergamma-
globulinaemia is a common feature in trypanosome infections, 
gammaglobulins may also play a role in binding of isometamidium 
in treated cases. It has been shown in this study that one of 
the drug binding proteins has a molecular weight of about 155 k D , 
which is within the range of gammaglobulins (150 - 160 k D ) , thus, 
gammaglobulins should be considered among the possible 
isometamidium binding proteins.
For the chemiluminescent assay, teflon membrane strips 
instead of gel-sized membranes can be used so as to minimise 
wastage of reagents. The use of biotinylated purified sheep 
anti-isometamidium IgG eliminates the use of a second antibody, 
for example, HRPO-conjugated donkey anti-sheep IgG. This 
increases the sensitivity of the assay due to the four binding 
sites available on the biotin molecule for the HRPO conjugated 
streptavidin. It also reduces the probability of species-cross 
reactions and non-specific binding, thus increasing the
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specificity of the assay.
The ability of the purified anti -isometamidium antibody to 
bind to isometamidium in sera of treated animals and 
isometamidium-protein conjugates or isometamidium-spiked proteins 
in the chemiluminescent assay indicates that the antibody is 
highly specific for isometamidium. Thus, chemiluminescent assays 
using this antibody could be performed in studies of the uptake 
of isometamidium chloride by trypanosomes in vitro and in v i v o ; 
and the antibody can also be used in assays for the 
quantification of isometamidium in body fluids.
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CHAPTER FOUR
THE DEVELOPMENT OF A "CHEMILUMINESCENT DOT-BLOT TECHNIQUE" FOR THE 
QUANTIFICATION OF ISOMETAMIDIUM IN THE SERUM OF TREATED ANIMALS
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INTRODUCTION
The work explained in this chapter was developed from the 
findings, reported in the preceding chapters, that about 99% of 
isometamidium is bound to serum proteins in treated animals. It 
has also been shown that a purified anti -isometamidium antibody 
is highly specific for the drug and it can be employed in a 
chemiluminescent assay to detect isometamidium bound to serum 
p r o t e i n s .
In chemiluminescent assays, the product of luminol 
oxidation, aminophthalate in an excited state decays to a ground 
state with the emission of light, X max 425 nm (Kricka and 
Thorpe, 1984). In samples containing higher amounts of 
the drug, the levels of interactions between anti-isometamidium 
antibody to isometamidium, and antibody-streptavidin peroxidase 
will increase, conversely more luminol will be oxidised resulting 
in emission of more light photons. The antithesis is also true.
It has been shown that photographic detection of
chemiluminescent and bioluminescent reactions is less expensive 
and simpler than measuring the light emission by a
photomultiplier tube or a silicon photodiode (Kricka and Thorpe,
1986). Also the use of Polaroid Type 612 instant film in
chemiluminescent and bioluminescent photographic assays, where 
luminol is the analyte, utilising horseradish peroxidase-peroxide 
system offers a limit of detection of 500 fmol.
This study attempted to take advantage of the ability of 
immobilon-P (a PVDF teflon membrane) to bind to proteins by 
applying the serum samples directly on the teflon membrane, and
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carrying out the chemiluminescent assay thereafter. It was the 
objective of this study to examine future possibilities of 
utilising the chemiluminescent assay for rapid quantification of 
isometamidium chloride in sera of treated animals.
MATERIALS AND METHODS
Materials
Samples included sera from cattle (Nos. 41, 42, 43 and 45)
on days 2, 16 and 30 after treatment with isometamidium at
0.5 mg/kg BW and their respective controls (Day 0).
Biotinylated sheep anti-isometamidium IgG (described in 
Chapter T h r e e ) . X-ray plates were obtained from Du Pont de 
Nemours (Deutschland) GMBH, Immobilin-P from Millipore, 
Streptavidin peroxidase, luminol and dimethyl sulfoxide from 
Sigma Chemical Company, and 4-iodophenol from Aldrich Chemical 
Company. Other chemicals and reagents were of analytical grade 
from British Drug House.
Methods
Serum samples were diluted serially using loading buffer 
(5 g SDS, 5 ml 1M TRIS pH 7.5, 2 ml 100 mM E D T A , 10 ml glycerol, 
2 ml 0.2% bromophenol blue all made to a final volume of 95 ml 
with distilled water, pH 6.8) and boiled for five minutes in a 
water bath.
A  teflon membrane was soaked in methanol for three minutes 
then transferred to a transfer buffer (9.1 g TRIS, 43.2 g 
glycine, 600 ml methanol made up to three litres with distilled 
water) and left to soak for another 5 - 1 0  minutes. Excess fluid
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was shaken off the teflon membrane, and the moist membrane laid 
on a 96 well micro-titre plate. The samples were applied as 5 yii 
dots on the teflon membrane arranged in an increasing dilution 
series. The membrane was left at room temperature for 30 minutes 
to enable the proteins to bind and the spotted samples to dry.
A chemiluminescent assay for isometamidium chloride on the 
teflon membrane was performed as detailed in Chapter Three.
RESULTS AND DISCUSSION
The density observed on the developed X-ray plate 
(Figure 23) decreases with increasing dilution of the serum 
samples, that is, the less isometamidium present in a sample 
results in a decrease of luminol oxidised and hence light photons 
emitted. The end-points of the different samples differ 
indicating that the sample which initially had a lower 
isometamidium concentration reached end-point detection by the 
polyclonal antibody first across the X-ray plate. Thus, visually 
a judgement can be made on which sample or which animal has a low 
level of isometamidium chloride and the vice-versa.
It is possible therefore, by utilising an end-point dilution 
of a standard isometamidium sample to estimate the amount of the 
drug contained in test samples run alongside, since the degree of 
exposure in a chemiluminescent assay is proportional to the 
intensity of light emission. The estimations of isometamidium in 
test samples are illustrated in Figure 24.
Scheneppenheim and Rautenberg (1988) demonstrated in their 
study of human immunodeficiency virus (HIV) that,
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Figure 23
Chemiluminescent Dot-blot Technique. Serially diluted 
serum samples after an exposure to x-ray film showing those 
without isometamidium chloride (F, G, I, K, L), with very 
low amount (C) and with fairly high amounts (A, B, D, E,
H, J).
Figure 24
Hypothetical Estimation of Isometamidium in Serum of Treated 
Animals (based on results obtained in Figure 23)
Assume (J) to be the standard sample:
The end-point of detection of isometamidium in (J) is 1/16 
which corresponds to 50 ng/ml isometamidium.
The original concentration of the sample is therefore 
16 x 50 — 800 n g / m l .
Likewise, the concentration in the unknown samples applied 
can be calculated, that is:-
Samples (D) and (H) contain: 128 x 50 ng/ml = 6.4 jug/ml. 
Samples (A), (B) and (E) contain: 64 x 50 ng/ml = 3.2 jug/ml.
chemiluminescent assays on blots are one hundred times more 
sensitive than either commercial ELISA or chromogenic peroxidase 
assay and detects seroconversion earlier than any other 
technique. For quantification of isometamidium, the sensitivity 
of the assay can be improved by the use of Polaroid Type 612 
(ASA 20,000) instant, black and white film. As regards the 
kinetics of light emission in this reaction, that is, a prolonged 
emission instead of a flash, then the use of Polaroid films will 
not pose any problems.
The improvement of chemiluminescent assay in the 
determination of isometamidium in blood of treated animals may 
offer advantages over other assays which utilise plasma or serum 
only. Since there are possibilities of isometamidium being bound 
to leucocytes and erythrocytes, then haemolysed blood samples can 
be used instead of plasma or serum in the chemiluminescent dot- 
blot, which may have otherwise interfered in the other assays for 
isometamidium chloride (spectrophotometric assay, H P L C , 
radioimmunoassay, ion-pair HPLC and ELISA). Likewise,
comparative studies on levels of the drug bound to cellular 
components and serum proteins can be undertaken.
The use of a Polaroid camera for this assay will offer the 
advantage of performing multiple assays simultaneously using a 
low cost portable instrument requiring no power source, and a 
permanent visual record can be obtained and stored. Thus, under 
field conditions, the photographic detection of the
chemiluminescent dot-blots could provide rapid information 
regarding drug levels in blood of isometamidium treated animals
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and therefore the presence of drug-resistant trypanosomes 
indirectly. The drawbacks of the photographic detection are that 
the film is less sensitive than a photomultiplier tube and the 
results are semiquantitative rather than quantitative unless 
neutral density filters or a densitometer is used (Kricka and 
T h o r p e , 1986) .
A chemiluminescent dot-blot technique could also be employed 
in serodiagnosis of African animal trypanosomiasis by using 
biotinylated monoclonal antibodies for the detection of 
trypanosomal antigens in the blood. Thus, from a single blood 
sample, disease diagnosis and determination of isometamidium 
levels could be carried out at minimal time in the field.
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CHAPTER FIVE
GENERAL CONCLUSIONS
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The foregoing studies have shown that in cattle treated by 
intramuscular injection of isometamidium chloride, the drug which 
is released into the circulation is bound to serum proteins (95 - 
99%) and very little, if any of it, is free and unbound.
In the studies to determine the extent of isometamidium 
binding to serum proteins, the separation of free and protein 
bound isometamidium by ultrafiltration was shown to be a superior 
method to TCA precipitation when their products (ultrafiltrates, 
redissolved TCA precipitates and supernatants) were analysed by 
ELISA since TCA was shown to affect the optical densities of the 
analytes in ELISA.
The extensive binding of isometamidium chloride to serum 
proteins has important implications for future studies on the 
uptake of the drug by trypanosomes. The possibility exists that 
the trypanosome surface coat glycoprotein has sites with higher 
affinity to isometamidium than the plasma proteins. Comparative 
studies of isometamidium binding to sensitive and resistant 
trypanosome surface coats should also be conducted.
Chemiluminescent studies showed that the serum proteins 
which bind isometamidium have molecular weights of about 122, 140 
and 155 kD in cattle and about 300 kD in goat and mice. In 
cattle, the protein of about 140 kD was suggested to be a dimer 
of bovine serum albumin. This molecule seems to be the main 
isometamidium binding protein compared to the other two which 
have not been fully characterised. Studies on binding of 
isometamidium to other serum proteins, particularly 
glycoproteins, lipoproteins and gammaglobulins, erythrocytes,
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leucocytes and platelets may also show other binding sites of 
importance.
Chemiluminescent studies have also revealed that a purified 
anti -isometamidium antibody produced in sheep using an 
isometamidium conjugated porcine thyroglobulin, is highly 
specific for isometamidium chloride and can be used in 
immunological assays for the detection and quantification of the 
drug in sera of treated a n i m a l s .
"Chemiluminescent Western-blot technique" is a sensitive and 
accurate method in characterisation of isometamidium binding 
proteins in serum, and may also be a useful technique in studying 
protein binding of other trypanocidal drugs, and possibly the 
uptake of these in vitro and in v i v o .
A  novel application of this technique "Chemiluminescent dot- 
blot" has shown a possibility of offering a simple, quick, less 
expensive and yet a sensitive method for the quantification of 
isometamidium in body fluids of treated animals under field 
conditions. The sensitivity and accuracy of the assay can be 
improved by using Polaroid Type 612 instant films in a polaroid 
camera incorporated with neutral density filters or using a 
densitometer. This technique also offers the possibilities of 
combining the determination of isometamidium levels with 
serodiagnosis of African animal trypanosomiasis from a single 
blood sample.
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